Download Zipped Amended WordPerfect SB0114.ZIP
[Introduced][Status][Bill Documents][Fiscal Note][Bills Directory]

S.B. 114


Text Box

- 1 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
This document includes Senate Committee Amendments incorporated into the bill on Fri, Feb 13, 2004 at 11:13 AM by rday. --> This document includes Senate 2nd Reading Floor Amendments incorporated into the bill on Fri, Feb 20, 2004 at 5:10 PM by rday. --> This document includes Senate 3rd Reading Floor Amendments incorporated into the bill on Tue, Feb 24, 2004 at 10:12 AM by rday. --> This document includes House Floor Amendments incorporated into the bill on Fri, Feb 27, 2004 at 5:50 PM by chopkin. -->              1
    
AMENDMENTS TO PRESCRIBING,

             2     
PREPARATION, AND DISPENSING OF

             3     
PRESCRIPTION DRUGS

             4     
2004 GENERAL SESSION

             5     
STATE OF UTAH

             6     
Sponsor: Peter C. Knudson

             7     

             8      LONG TITLE
             9      General Description:
             10          This bill repeals the current Pharmacy Practice Act and enacts a new Pharmacy Practice
             11      Act.
             12      Highlighted Provisions:
             13          This bill:
             13a           S . AMENDS THE DEFINITION OF UNLAWFUL AND UNPROFESSIONAL CONDUCT TO
             13b      INCLUDE PRESCRIBING A DRUG OR DEVICE WITHOUT A DIAGNOSIS OR A BONA FIDE
             13c      PATIENT-PRACTITIONER RELATIONSHIP; s
             14          .    enacts a new Pharmacy Practice Act and includes:
             15              .    definitions;
             16              .    administrative inspections;
             17              .    board membership, qualifications, and terms;
             18              .    license classifications for pharmacy facilities;
             19              .    qualifications for licensure as a pharmacist;
             20              .    qualifications for licensure as a pharmacy intern;
             21              .    qualifications for licensure as a pharmacy technician;
             22              .    qualifications for licensure as a pharmacy;
             23              .    criminal background checks;
             24              .    terms of license;
             25              .    exemptions from licensure;
             26              .    continuing education;
             27              .    grounds for denial of licensure;



Text Box

- 2 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
             28
             .    provisions related to unlawful and unprofessional conduct;
             29              .    regulation of the practice of pharmacy operating standards; and
             30              .    provisions related to incapacitated pharmacists;
             31          .    amends the sunset date of the Pharmacy Practice Act to July 1, 2014; and
             32          .    makes technical amendments.
             33      Monies Appropriated in this Bill:
             34          None
             35      Other Special Clauses:
             36          This bill takes effect on July 1, 2004.
             37      Utah Code Sections Affected:
             38      AMENDS:
             39          16-11-2, as last amended by Chapter 185, Laws of Utah 2002
             40          26-18-2.3, as last amended by Chapter 324, Laws of Utah 2003
             41          26-18-101, as last amended by Chapters 79, 247 and 248, Laws of Utah 1996
             42          26-47-101, as enacted by Chapter 310, Laws of Utah 2003
             43          48-2c-1502, as last amended by Chapter 185, Laws of Utah 2002
             44          58-1-307, as last amended by Chapter 3, Laws of Utah 2003
             44a           S 58-1-501, AS LAST AMENDED BY CHAPTER 148, LAWS OF UTAH 2001 s
             45          58-16a-102, as last amended by Chapter 270, Laws of Utah 2003
             46          58-24a-105, as last amended by Chapter 247, Laws of Utah 1996
             47          58-37-6, as last amended by Chapter 33, Laws of Utah 2003
             48          58-37-7.5, as last amended by Chapter 33, Laws of Utah 2003
             49          58-37c-19.5, as enacted by Chapter 272, Laws of Utah 2000
             50          58-71-102, as last amended by Chapter 131, Laws of Utah 2003
             51          58-71-801, as enacted by Chapter 282, Laws of Utah 1996
             52          58-73-601, as last amended by Chapter 284, Laws of Utah 1998
             53          63-55-258, as last amended by Chapters 49 and 254, Laws of Utah 2003
             54          76-5-113, as enacted by Chapter 164, Laws of Utah 2001
             55          76-8-311.3, as last amended by Chapter 8, Laws of Utah 2002, Fifth Special Session
             56          78-11-22.2, as enacted by Chapter 152, Laws of Utah 2000
             57          78-14-3, as last amended by Chapter 131, Laws of Utah 2002
             58      ENACTS:



Text Box

- 3 -
             59
         58-17b-101, Utah Code Annotated 1953
             60          58-17b-102, Utah Code Annotated 1953
             61          58-17b-103, Utah Code Annotated 1953
             62          58-17b-201, Utah Code Annotated 1953
             63          58-17b-301, Utah Code Annotated 1953
             64          58-17b-302, Utah Code Annotated 1953
             65          58-17b-303, Utah Code Annotated 1953
             66          58-17b-304, Utah Code Annotated 1953
             67          58-17b-305, Utah Code Annotated 1953
             68          58-17b-306, Utah Code Annotated 1953
             69          58-17b-307, Utah Code Annotated 1953
             70          58-17b-308, Utah Code Annotated 1953
             71          58-17b-309, Utah Code Annotated 1953
             72          58-17b-310, Utah Code Annotated 1953
             73          58-17b-401, Utah Code Annotated 1953
             74          58-17b-501, Utah Code Annotated 1953
             75          58-17b-502, Utah Code Annotated 1953
             76          58-17b-503, Utah Code Annotated 1953
             77          58-17b-504, Utah Code Annotated 1953
             78          58-17b-505, Utah Code Annotated 1953
             79          58-17b-506, Utah Code Annotated 1953
             80          58-17b-601, Utah Code Annotated 1953
             81          58-17b-602, Utah Code Annotated 1953
             82          58-17b-603, Utah Code Annotated 1953
             83          58-17b-604, Utah Code Annotated 1953
             84          58-17b-605, Utah Code Annotated 1953
             85          58-17b-606, Utah Code Annotated 1953
             86          58-17b-607, Utah Code Annotated 1953
             87          58-17b-608, Utah Code Annotated 1953
             88          58-17b-609, Utah Code Annotated 1953
             89          58-17b-610, Utah Code Annotated 1953



Text Box

- 4 -
             90
         58-17b-611, Utah Code Annotated 1953
             91          58-17b-612, Utah Code Annotated 1953
             92          58-17b-613, Utah Code Annotated 1953
             93          58-17b-614, Utah Code Annotated 1953
             94          58-17b-615, Utah Code Annotated 1953
             95          58-17b-616, Utah Code Annotated 1953
             96          58-17b-617, Utah Code Annotated 1953
             97          58-17b-618, Utah Code Annotated 1953
             98          58-17b-619, Utah Code Annotated 1953
             99          58-17b-620, Utah Code Annotated 1953
             100          58-17b-621, Utah Code Annotated 1953
             101          58-17b-701, Utah Code Annotated 1953
             102      REPEALS:
             103          58-17a-101, as enacted by Chapter 247, Laws of Utah 1996
             104          58-17a-102, as last amended by Chapter 184, Laws of Utah 2002
             105          58-17a-103, as enacted by Chapter 28, Laws of Utah 1998
             106          58-17a-201, as enacted by Chapter 247, Laws of Utah 1996
             107          58-17a-301, as enacted by Chapter 247, Laws of Utah 1996
             108          58-17a-302, as last amended by Chapter 28, Laws of Utah 1998
             109          58-17a-304, as enacted by Chapter 247, Laws of Utah 1996
             110          58-17a-305, as last amended by Chapter 160, Laws of Utah 2000
             111          58-17a-401, as enacted by Chapter 247, Laws of Utah 1996
             112          58-17a-402, as enacted by Chapter 247, Laws of Utah 1996
             113          58-17a-501, as last amended by Chapter 28, Laws of Utah 1998
             114          58-17a-502, as last amended by Chapter 184, Laws of Utah 2002
             115          58-17a-502.5, as enacted by Chapter 18, Laws of Utah 2002, Fifth Special Session
             116          58-17a-503, as enacted by Chapter 247, Laws of Utah 1996
             117          58-17a-601, as enacted by Chapter 247, Laws of Utah 1996
             118          58-17a-602, as enacted by Chapter 247, Laws of Utah 1996
             119          58-17a-603, as enacted by Chapter 247, Laws of Utah 1996
             120          58-17a-604, as enacted by Chapter 247, Laws of Utah 1996



Text Box

- 5 -
             121
         58-17a-605, as enacted by Chapter 247, Laws of Utah 1996
             122          58-17a-606, as enacted by Chapter 247, Laws of Utah 1996
             123          58-17a-607, as enacted by Chapter 247, Laws of Utah 1996
             124          58-17a-608, as enacted by Chapter 247, Laws of Utah 1996
             125          58-17a-609, as enacted by Chapter 247, Laws of Utah 1996
             126          58-17a-610, as enacted by Chapter 247, Laws of Utah 1996
             127          58-17a-611, as last amended by Chapter 344, Laws of Utah 2001
             128          58-17a-612, as enacted by Chapter 247, Laws of Utah 1996
             129          58-17a-613, as enacted by Chapter 247, Laws of Utah 1996
             130          58-17a-614, as enacted by Chapter 247, Laws of Utah 1996
             131          58-17a-615, as enacted by Chapter 247, Laws of Utah 1996
             132          58-17a-616, as enacted by Chapter 247, Laws of Utah 1996
             133          58-17a-617, as enacted by Chapter 247, Laws of Utah 1996
             134          58-17a-618, as enacted by Chapter 247, Laws of Utah 1996
             135          58-17a-619, as enacted by Chapter 247, Laws of Utah 1996
             136          58-17a-620, as last amended by Chapter 3, Laws of Utah 2003
             137          58-17a-701, as enacted by Chapter 247, Laws of Utah 1996
             138          58-17a-801, as last amended by Chapter 8, Laws of Utah 2002, Fifth Special Session
             139     

             140      Be it enacted by the Legislature of the state of Utah:
             141          Section 1. Section 16-11-2 is amended to read:
             142           16-11-2. Definitions.
             143          As used in this chapter:
             144          (1) "Filed" means the division has received and approved, as to form, a document
             145      submitted under the provisions of this chapter, and has marked on the face of the document a
             146      stamp or seal indicating the time of day and date of approval, the name of the division, the
             147      division director's signature and division seal, or facsimiles of the signature or seal.
             148          (2) "Professional corporation" means a corporation organized under this chapter.
             149          (3) "Professional service" means the personal service rendered by:
             150          (a) a physician, surgeon, or doctor of medicine holding a license under Title 58,
             151      Chapter 67, Utah Medical Practice Act, and any subsequent laws regulating the practice of



Text Box

- 6 -
             152
     medicine;
             153          (b) a doctor of dentistry holding a license under Title 58, Chapter 69, Dentist and
             154      Dental Hygienist Practice Act, and any subsequent laws regulating the practice of dentistry;
             155          (c) an osteopathic physician or surgeon holding a license under Title 58, Chapter 68,
             156      Utah Osteopathic Medical Practice Act, and any subsequent laws regulating the practice of
             157      osteopathy;
             158          (d) a chiropractor holding a license under Title 58, Chapter 73, Chiropractic Physician
             159      Practice Act, and any subsequent laws regulating the practice of chiropractic;
             160          (e) a podiatric physician holding a license under Title 58, Chapter 5a, Podiatric
             161      Physician Licensing Act, and any subsequent laws regulating the practice of podiatry;
             162          (f) an optometrist holding a license under Title 58, Chapter 16a, Utah Optometry
             163      Practice Act, and any subsequent laws regulating the practice of optometry;
             164          (g) a veterinarian holding a license under Title 58, Chapter 28, Veterinary Practice Act,
             165      and any subsequent laws regulating the practice of veterinary medicine;
             166          (h) an architect holding a license under Title 58, Chapter 3a, Architects Licensing Act,
             167      and any subsequent laws regulating the practice of architecture;
             168          (i) a public accountant holding a license under Title 58, Chapter 26a, Certified Public
             169      Accountant Licensing Act, and any subsequent laws regulating the practice of public
             170      accounting;
             171          (j) a naturopath holding a license under Title 58, Chapter 71, Naturopathic Physician
             172      Practice Act, and any subsequent laws regulating the practice of naturopathy;
             173          (k) a pharmacist holding a license under Title 58, Chapter [17a] 17b, Pharmacy
             174      Practice Act, and any subsequent laws regulating the practice of pharmacy;
             175          (l) an attorney granted the authority to practice law by:
             176          (i) the Utah Supreme Court; or
             177          (ii) the Supreme Court, other court, agency, instrumentality, or regulating board that
             178      licenses or regulates the authority to practice law in any state or territory of the United States
             179      other than Utah;
             180          (m) a professional engineer registered under Title 58, Chapter 22, Professional
             181      Engineers and Professional Land Surveyor Licensing Act;
             182          (n) a real estate broker or real estate agent holding a license under Title 61, Chapter 2,



Text Box

- 7 -
             183
     Division of Real Estate, and any subsequent laws regulating the selling, exchanging,
             184      purchasing, renting, or leasing of real estate;
             185          (o) a psychologist holding a license under Title 58, Chapter 61, Psychologist Licensing
             186      Act, and any subsequent laws regulating the practice of psychology;
             187          (p) a clinical or certified social worker holding a license under Title 58, Chapter 60,
             188      Part 2, Social Worker Licensing Act, and any subsequent laws regulating the practice of social
             189      work;
             190          (q) a physical therapist holding a license under Title 58, Chapter 24a, Physical
             191      Therapist Practice Act, and any subsequent laws regulating the practice of physical therapy; or
             192          (r) a nurse licensed under Title 58, Chapter 31b, Nurse Practice Act, or Title 58,
             193      Chapter 44a, Nurse Midwife Practice Act.
             194          (4) "Regulating board" means the board that is charged with the licensing and
             195      regulation of the practice of the profession which the professional corporation is organized to
             196      render. The definitions of Title 16, Chapter 10a, Utah Revised Business Corporation Act,
             197      apply to this chapter unless the context clearly indicates that a different meaning is intended.
             198          Section 2. Section 26-18-2.3 is amended to read:
             199           26-18-2.3. Division responsibilities -- Emphasis -- Periodic assessment.
             200          (1) In accordance with the requirements of Title XIX of the Social Security Act and
             201      applicable federal regulations, the division is responsible for the effective and impartial
             202      administration of this chapter in an efficient, economical manner. The division shall:
             203          (a) establish, on a statewide basis, a program to safeguard against unnecessary or
             204      inappropriate use of Medicaid services, excessive payments, and unnecessary or inappropriate
             205      hospital admissions or lengths of stay;
             206          (b) deny any provider claim for services that fail to meet criteria established by the
             207      division concerning medical necessity or appropriateness; and
             208          (c) place its emphasis on high quality care to recipients in the most economical and
             209      cost-effective manner possible, with regard to both publicly and privately provided services.
             210          (2) The division shall implement and utilize cost-containment methods, where
             211      possible, which may include, but are not limited to:
             212          (a) prepayment and postpayment review systems to determine if utilization is
             213      reasonable and necessary;



Text Box

- 8 -
             214
         (b) preadmission certification of nonemergency admissions;
             215          (c) mandatory outpatient, rather than inpatient, surgery in appropriate cases;
             216          (d) second surgical opinions;
             217          (e) procedures for encouraging the use of outpatient services;
             218          (f) consistent with Sections 28-18-2.4 and [ 58-17a-605.1 ] 58-17b-606 , a Medicaid
             219      drug program;
             220          (g) coordination of benefits; and
             221          (h) review and exclusion of providers who are not cost effective or who have abused
             222      the Medicaid program, in accordance with the procedures and provisions of federal law and
             223      regulation.
             224          (3) The director of the division shall periodically assess the cost effectiveness and
             225      health implications of the existing Medicaid program, and consider alternative approaches to
             226      the provision of covered health and medical services through the Medicaid program, in order to
             227      reduce unnecessary or unreasonable utilization.
             228          Section 3. Section 26-18-101 is amended to read:
             229           26-18-101. Definitions.
             230          As used in this part:
             231          (1) "Appropriate and medically necessary" means, regarding drug prescribing,
             232      dispensing, and patient usage, that it is in conformity with the criteria and standards developed
             233      in accordance with this part.
             234          (2) "Board" means the Drug Utilization Review Board created in Section 26-18-102 .
             235          (3) "Compendia" means resources widely accepted by the medical profession in the
             236      efficacious use of drugs, including "American Hospital Formulary Services Drug Information,"
             237      "U.S. Pharmacopeia - Drug Information," "A.M.A. Drug Evaluations," peer-reviewed medical
             238      literature, and information provided by manufacturers of drug products.
             239          (4) "Counseling" means the activities conducted by a pharmacist to inform Medicaid
             240      recipients about the proper use of drugs, as required by the board under this part.
             241          (5) "Criteria" means those predetermined and explicitly accepted elements used to
             242      measure drug use on an ongoing basis in order to determine if the use is appropriate, medically
             243      necessary, and not likely to result in adverse medical outcomes.
             244          (6) "Drug-disease contraindications" means that the therapeutic effect of a drug is



Text Box

- 9 -
             245
     adversely altered by the presence of another disease condition.
             246          (7) "Drug-interactions" means that two or more drugs taken by a recipient lead to
             247      clinically significant toxicity that is characteristic of one or any of the drugs present, or that
             248      leads to interference with the effectiveness of one or any of the drugs.
             249          (8) "Drug Utilization Review" or "DUR" means the program designed to measure and
             250      assess, on a retrospective and prospective basis, the proper use of outpatient drugs in the
             251      Medicaid program.
             252          (9) "Intervention" means a form of communication utilized by the board with a
             253      prescriber or pharmacist to inform about or influence prescribing or dispensing practices.
             254          (10) "Overutilization" or "underutilization" means the use of a drug in such quantities
             255      that the desired therapeutic goal is not achieved.
             256          (11) "Pharmacist" means a person licensed in this state to engage in the practice of
             257      pharmacy under Title 58, Chapter [17a] 17b, Pharmacy Practice Act.
             258          (12) "Physician" means a person licensed in this state to practice medicine and surgery
             259      under Section 58-67-301 [, Utah Medical Practice Act,] or osteopathic medicine under Section
             260      58-68-301 [, Utah Osteopathic Medical Practice Act].
             261          (13) "Prospective DUR" means that part of the drug utilization review program that
             262      occurs before a drug is dispensed, and that is designed to screen for potential drug therapy
             263      problems based on explicit and predetermined criteria and standards.
             264          (14) "Retrospective DUR" means that part of the drug utilization review program that
             265      assesses or measures drug use based on an historical review of drug use data against
             266      predetermined and explicit criteria and standards, on an ongoing basis with professional input.
             267          (15) "Standards" means the acceptable range of deviation from the criteria that reflects
             268      local medical practice and that is tested on the Medicaid recipient database.
             269          (16) "SURS" means the Surveillance Utilization Review System of the Medicaid
             270      program.
             271          (17) "Therapeutic appropriateness" means drug prescribing and dispensing based on
             272      rational drug therapy that is consistent with criteria and standards.
             273          (18) "Therapeutic duplication" means prescribing and dispensing the same drug or two
             274      or more drugs from the same therapeutic class where periods of drug administration overlap
             275      and where that practice is not medically indicated.



Text Box

- 10 -
             276
         Section 4. Section 26-47-101 is amended to read:
             277           26-47-101. Prescription Drug Assistance Program.
             278          (1) No later than October 1, 2003, the department shall implement a Prescription Drug
             279      Assistance Program. The program shall assist persons seeking information about how to obtain
             280      prescription drugs at a reduced price or no cost. The program shall:
             281          (a) collect eligibility and enrollment information about programs that make
             282      prescription drugs available to consumers at a reduced price or no cost;
             283          (b) provide information collected under Subsection (1)(a) to consumers upon request
             284      via a toll-free phone line, the Internet, and mail;
             285          (c) inform pharmacists and other health care providers of the Prescription Drug
             286      Assistance Program; and
             287          (d) assist consumers in completing applications to participate in programs identified
             288      under Subsection (1)(a).
             289          (2) Any pharmaceutical manufacturer, distributor, or wholesaler operating in the state
             290      shall:
             291          (a) notify the department of any program operated by it to provide prescription drugs to
             292      consumers at a reduced price or no cost; and
             293          (b) provide the department with information about eligibility, enrollment, and benefits.
             294          (3) Pharmacies, as defined in Title 58, Chapter [17] 17b, Pharmacy Practice Act, shall
             295      notify their patients of the Prescription Drug Assistance Program. This notification shall
             296      include displaying the program's toll-free number, and may include distributing a brochure or
             297      oral communication.
             298          (4) The department may accept grants, gifts, and donations of money or property for
             299      use by the Prescription Drug Assistance Program.
             300          (5) The department shall report to the Health and Human Services Interim Committee
             301      and the Joint Health and Human Services Appropriations Subcommittee on the performance of
             302      the Prescription Drug Assistance Program prior to the 2004 and 2005 Annual General Sessions
             303      of the Legislature.
             304          Section 5. Section 48-2c-1502 is amended to read:
             305           48-2c-1502. Definitions.
             306          As used in this part:



Text Box

- 11 -
             307
         (1) "Professional services company" means a limited liability company organized
             308      under this part to render professional services.
             309          (2) "Professional services" means the personal services rendered by:
             310          (a) an architect holding a license under Title 58, Chapter 3a, Architects Licensing Act,
             311      and any subsequent laws regulating the practice of architecture;
             312          (b) an attorney granted the authority to practice law by the:
             313          (i) Supreme Court of Utah; or
             314          (ii) the Supreme Court, other court, agency, instrumentality, or regulating board that
             315      licenses or regulates the authority to practice law in any state or territory of the United States
             316      other than Utah;
             317          (c) a chiropractor holding a license under Title 58, Chapter 73, Chiropractic Physician
             318      Practice Act, and any subsequent laws regulating the practice of chiropractic;
             319          (d) a doctor of dentistry holding a license under Title 58, Chapter 69, Dentists and
             320      Dental Hygienists Practice Act, and any subsequent laws, regulating the practice of dentistry;
             321          (e) a professional engineer registered under Title 58, Chapter 22, Professional
             322      Engineers and Professional Land Surveyors Licensing Act;
             323          (f) a naturopath holding a license under Title 58, Chapter 71, Naturopathic Physician
             324      Practice Act, and any subsequent laws regulating the practice of naturopathy;
             325          (g) a nurse licensed under Title 58, Chapter 31b, Nurse Practice Act, or Title 58,
             326      Chapter 44a, Nurse Midwife Practice Act;
             327          (h) an optometrist holding a license under Title 58, Chapter 16a, Utah Optometry
             328      Practice Act, and any subsequent laws regulating the practice of optometry;
             329          (i) an osteopathic physician or surgeon holding a license under Title 58, Chapter 68,
             330      Utah Osteopathic Medical Practice Act, and any subsequent laws regulating the practice of
             331      osteopathy;
             332          (j) a pharmacist holding a license under Title 58, Chapter [17a] 17b, Pharmacy Practice
             333      Act, and any subsequent laws regulating the practice of pharmacy;
             334          (k) a physician, surgeon, or doctor of medicine holding a license under Title 58,
             335      Chapter 67, Utah Medical Practice Act, and any subsequent laws regulating the practice of
             336      medicine;
             337          (l) a physical therapist holding a license under Title 58, Chapter 24a, Physical



Text Box

- 12 -
             338
     Therapist Practice Act, and any subsequent laws regulating the practice of physical therapy;
             339          (m) a podiatric physician holding a license under Title 58, Chapter 5a, Podiatric
             340      Physician Licensing Act, and any subsequent laws regulating the practice of podiatry;
             341          (n) a psychologist holding a license under Title 58, Chapter 61, Psychologist Licensing
             342      Act, and any subsequent laws regulating the practice of psychology;
             343          (o) a public accountant holding a license under Title 58, Chapter 26a, Certified Public
             344      Accountant Licensing Act, and any subsequent laws regulating the practice of public
             345      accounting;
             346          (p) a real estate broker or real estate agent holding a license under Title 61, Chapter 2,
             347      Division of Real Estate, and any subsequent laws regulating the sale, exchange, purchase,
             348      rental, or leasing of real estate;
             349          (q) a clinical or certified social worker holding a license under Title 58, Chapter 60,
             350      Part 2, Social Worker Licensing Act, and any subsequent laws regulating the practice of social
             351      work;
             352          (r) a mental health therapist holding a license under Title 58, Chapter 60, Mental
             353      Health Professional Practice Act, and any subsequent laws regulating the practice of mental
             354      health therapy; and
             355          (s) a veterinarian holding a license under Title 58, Chapter 28, Veterinary Practice Act,
             356      and any subsequent laws regulating the practice of veterinary medicine.
             357          (3) "Regulating board" means the board or agency organized pursuant to state law that
             358      is charged with the licensing and regulation of the practice of the profession that a company is
             359      organized to render.
             360          Section 6. Section 58-1-307 is amended to read:
             361           58-1-307. Exemptions from licensure.
             362          (1) Except as otherwise provided by statute or rule, the following persons may engage
             363      in the practice of their occupation or profession, subject to the stated circumstances and
             364      limitations, without being licensed under this title:
             365          (a) a person serving in the armed forces of the United States, the United States Public
             366      Health Service, the United States Department of Veterans Affairs, or other federal agencies
             367      while engaged in activities regulated under this chapter as a part of employment with that
             368      federal agency if the person holds a valid license to practice a regulated occupation or



Text Box

- 13 -
             369
     profession issued by any other state or jurisdiction recognized by the division;
             370          (b) a student engaged in activities constituting the practice of a regulated occupation or
             371      profession while in training in a recognized school approved by the division to the extent the
             372      activities are supervised by qualified faculty, staff, or designee and the activities are a defined
             373      part of the training program;
             374          (c) an individual engaged in an internship, residency, preceptorship, postceptorship,
             375      fellowship, apprenticeship, or on-the-job training program approved by the division while
             376      under the supervision of qualified persons;
             377          (d) an individual residing in another state and licensed to practice a regulated
             378      occupation or profession in that state, who is called in for a consultation by an individual
             379      licensed in this state, and the services provided are limited to that consultation;
             380          (e) an individual who is invited by a recognized school, association, society, or other
             381      body approved by the division to conduct a lecture, clinic, or demonstration of the practice of a
             382      regulated occupation or profession if the individual does not establish a place of business or
             383      regularly engage in the practice of the regulated occupation or profession in this state;
             384          (f) an individual licensed under the laws of this state, other than under this title, to
             385      practice or engage in an occupation or profession, while engaged in the lawful, professional,
             386      and competent practice of that occupation or profession;
             387          (g) an individual licensed in a health care profession in another state who performs that
             388      profession while attending to the immediate needs of a patient for a reasonable period during
             389      which the patient is being transported from outside of this state, into this state, or through this
             390      state;
             391          (h) an individual licensed in another state or country who is in this state temporarily to
             392      attend to the needs of an athletic team or group, except that the practitioner may only attend to
             393      the needs of the athletic team or group, including all individuals who travel with the team or
             394      group in any capacity except as a spectator;
             395          (i) an individual licensed and in good standing in another state, who is in this state:
             396          (i) temporarily, under the invitation and control of a sponsoring entity;
             397          (ii) for a reason associated with a special purpose event, based upon needs that may
             398      exceed the ability of this state to address through its licensees, as determined by the division;
             399      and



Text Box

- 14 -
             400
         (iii) for a limited period of time not to exceed the duration of that event, together with
             401      any necessary preparatory and conclusionary periods. The requirements of Section
             402      63A-10-105 do not apply to exemptions authorized by the division pursuant to this Subsection
             403      (1)(i);
             404          (j) an individual who:
             405          (i) is certified as an athletic trainer by the National Athletic Trainers Association Board
             406      of Certification or another entity approved by the division;
             407          (ii) is employed or officially associated with an educational institution, a professional
             408      sports organization, or a bona fide amateur sports organization; and
             409          (iii) only provides athletic training services:
             410          (A) to athletes of the educational institution or sports organization to which the
             411      individual is employed or officially associated;
             412          (B) at an official athletic training, practice, or competition site; and
             413          (C) that are within the scope of the individual's certification; and
             414          (k) a law enforcement officer, as defined under Section 53-13-103 , who:
             415          (i) is operating a voice stress analyzer in the course of the officer's full-time
             416      employment with a federal, state, or local law enforcement agency;
             417          (ii) has completed the manufacturer's training course and is certified by the
             418      manufacturer to operate that voice stress analyzer; and
             419          (iii) is operating the voice stress analyzer in accordance with Section 58-64-601 ,
             420      regarding deception detection instruments.
             421          (2) A practitioner temporarily in this state who is exempted from licensure under
             422      Subsection (1) shall comply with each requirement of the licensing jurisdiction from which the
             423      practitioner derives authority to practice. Violation of any limitation imposed by this section
             424      constitutes grounds for removal of exempt status, denial of license, or other disciplinary
             425      proceedings.
             426          (3) An individual who is licensed under a specific chapter of this title to practice or
             427      engage in an occupation or profession may engage in the lawful, professional, and competent
             428      practice of that occupation or profession without additional licensure under other chapters of
             429      this title, except as otherwise provided by this title.
             430          (4) Upon the declaration of a national, state, or local emergency, a public health



Text Box

- 15 -
             431
     emergency as defined in Section 26-23b-102 , or a declaration by the President of the United
             432      States or other federal official requesting public health-related activities, the division in
             433      collaboration with the board may:
             434          (a) suspend the requirements for permanent or temporary licensure of persons who are
             435      licensed in another state. Persons exempt under this Subsection (4)(a) shall be exempt from
             436      licensure for the duration of the emergency while engaged in the scope of practice for which
             437      they are licensed in the other state;
             438          (b) modify, under the circumstances described in [Subsections] this Subsection (4) and
             439      Subsection (5), the scope of practice restrictions under this title for persons who are licensed
             440      under this title as:
             441          (i) a physician under Chapter 67, Utah Medical Practice Act, or Chapter 68, Utah
             442      Osteopathic Medical Practice Act;
             443          (ii) a nurse under Chapter 31b, Nurse Practice Act, or Chapter 31c, Nurse Licensure
             444      Compact;
             445          (iii) a certified nurse midwife under Chapter 44a, Nurse Midwife Practice Act;
             446          (iv) a pharmacist, pharmacy technician, or pharmacy intern under Chapter [17a] 17b,
             447      Pharmacy Practice Act;
             448          (v) a respiratory therapist under Chapter 57, Respiratory Care Practices Act; and
             449          (vi) a dentist and dental hygienist under Chapter 69, Dentist and Dental Hygienist
             450      Practice Act;
             451          (c) suspend the requirements for licensure under this title and modify the scope of
             452      practice in the circumstances described in [Subsections] this Subsection (4) and Subsection (5)
             453      for medical services personnel or paramedics required to be certified under Section 26-8a-302 ;
             454      and
             455          (d) suspend requirements in Subsections [ 58-17a-620 ] 58-17b-620 (3) through (6)
             456      which require certain prescriptive procedures.
             457          (5) Persons exempt under Subsection (4)(c) and persons operating under modified
             458      scope of practice provisions under Subsection (4)(b):
             459          (a) shall be exempt from licensure or subject to modified scope of practice for the
             460      duration of the emergency;
             461          (b) must be engaged in the distribution of medicines or medical devises in response to



Text Box

- 16 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
             462
     the emergency or declaration; and
             463          (c) must be employed by or volunteering for a local or state department of health.
             464          Section 7. Section 58-16a-102 is amended to read:
             464a      S Section 7. Section 58-1-501 is amended to read:
             464b          58-1-501.   Unlawful and unprofessional conduct.
             464c          (1) "Unlawful conduct" means conduct, by any person, that is defined as unlawful under this
             464d      title and includes:
             464e          (a) practicing or engaging in, representing oneself to be practicing or engaging in, or
             464f      attempting to practice or engage in any occupation or profession requiring licensure under this title if
             464g      the person is:
             464h          (i) not licensed to do so or not exempted from licensure under this title; or
             464i          (ii) restricted from doing so by a suspended, revoked, restricted, temporary, probationary, or
             464j      inactive license;
             464k          (b) impersonating another licensee or practicing an occupation or profession under a false or
             464l      assumed name, except as permitted by law;
             464m          (c) knowingly employing any other person to practice or engage in or attempt to practice or
             464n      engage in any occupation or profession licensed under this title if the employee is not licensed to do
             464o      so under this title;
             464p          (d) knowingly permitting the person's authority to practice or engage in any occupation or
             464q      profession licensed under this title to be used by another, except as permitted by law; [or]
             464r          (e) obtaining a passing score on a licensure examination, applying for or obtaining a license,
             464s      or otherwise dealing with the division or a licensing board through the use of fraud, forgery, or
             464t      intentional deception, misrepresentation, misstatement, or omission[.];
             464u          (f) UNLESS SUBSECTION (2)(m) OR (3) APPLIES, ISSUING, OR AIDING AND ABETTING IN THE
             464v      ISSUANCE OF, AN ORDER OR PRESCRIPTION FOR A DRUG OR DEVICE TO A PERSON LOCATED IN
             464w      THIS STATE:
             464x          (i) WITHOUT PRESCRIPTIVE AUTHORITY CONFERRED BY A LICENSE ISSUED UNDER THIS
             464y      TITLE, OR BY AN EXEMPTION TO LICENSURE UNDER THIS TITLE;
             464z          (ii) WITH PRESCRIPTIVE AUTHORITY CONFERRED BY AN EXCEPTION ISSUED UNDER THIS
             464aa      TITLE OR A MULTISTATE PRACTICE PRIVILEGE RECOGNIZED UNDER THIS TITLE, IF THE
             464ab      PRESCRIPTION WAS ISSUED:
             464ac          (A) WITHOUT FIRST OBTAINING INFORMATION, IN THE USUAL COURSE OF PROFESSIONAL
             464ad      PRACTICE, THAT IS SUFFICIENT TO ESTABLISH A DIAGNOSIS, TO IDENTIFY UNDERLYING
             464ae      CONDITIONS, AND TO IDENTIFY CONTRAINDICATIONS TO THE PROPOSED TREATMENT; OR
             464af          (B) BASED ON A QUESTIONNAIRE COMPLETED BY THE PATIENT ON THE INTERNET, OR
             464ag      TOLL-FREE TELEPHONE NUMBER, WHEN THERE EXISTS NO OTHER BONA-FIDE
             464ah      PATIENT-PRACTITIONER RELATIONSHIP; OR
             464ai          (iii) IN VIOLATION OF SUBSECTION (2)(m), WHEN THE LICENSED PERSON WHO ISSUED,

OR
             464aj      AIDED AND ABETTED ANOTHER IN THE ISSUANCE OF THE PRESCRIPTION HAS VIOLATED
             464ak      SUBSECTION (2)(m) ON MORE THAN 100 PRESCRIPTIONS WITHIN A THIRTY DAY PERIOD OF TIME;
             464al      AND
             464am          (g) SUBSECTION (2)(f) DOES NOT APPLY TO TREATMENT RENDERED IN AN EMERGENCY,
             464an      ON-CALL OR CROSS COVERAGE SITUATION, PROVIDED THAT THE PERSON WHO ISSUES s


            
Text Box

- 16a -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
464ao
     S THE PRESCRIPTION HAS PRESCRIPTIVE AUTHORITY CONFERRED BY A LICENSE UNDER THIS
             464ap      TITLE, OR IS EXEMPT FROM LICENSURE UNDER THIS TITLE.
             464aq          (2) "Unprofessional conduct" means conduct, by a licensee or applicant, that is defined as
             464ar      unprofessional conduct under this title or under any rule adopted under this title and includes:
             464as          (a) violating, or aiding or abetting any other person to violate, any statute, rule, or order
             464at      regulating an occupation or profession under this title;
             464au          (b) violating, or aiding or abetting any other person to violate, any generally accepted
             464av      professional or ethical standard applicable to an occupation or profession regulated under this title;
             464aw          (c) engaging in conduct that results in conviction, a plea of nolo contendere, or a plea of
             464ax      guilty or nolo contendere which is held in abeyance pending the successful completion of probation
             464ay      with respect to a crime of moral turpitude or any other crime that, when considered with the functions
             464az      and duties of the occupation or profession for which the license was issued or is to be issued, bears a
             464ba      reasonable relationship to the licensee's or applicant's ability to safely or competently practice the
             464bb      occupation or profession;
             464bc          (d) engaging in conduct that results in disciplinary action, including reprimand, censure,
             464bd      diversion, probation, suspension, or revocation, by any other licensing or regulatory authority having
             464be      jurisdiction over the licensee or applicant in the same occupation or profession if the conduct would,
             464bf      in this state, constitute grounds for denial of licensure or disciplinary proceedings under Section
             464bg      58-1-401;
             464bh          (e) engaging in conduct, including the use of intoxicants, drugs, narcotics, or similar
             464bi      chemicals, to the extent that the conduct does, or might reasonably be considered to, impair the
             464bj      ability of the licensee or applicant to safely engage in the occupation or profession;
             464bk          (f) practicing or attempting to practice an occupation or profession regulated under this title
             464bl      despite being physically or mentally unfit to do so;
             464bm          (g) practicing or attempting to practice an occupation or profession regulated under this title
             464bn      through gross incompetence, gross negligence, or a pattern of incompetency or negligence;
             464bo          (h) practicing or attempting to practice an occupation or profession requiring licensure under
             464bp      this title by any form of action or communication which is false, misleading, deceptive, or fraudulent;
             464bq          (i) practicing or attempting to practice an occupation or profession regulated under this title
             464br      beyond the scope of the licensee's competency, abilities, or education;
             464bs          (j) practicing or attempting to practice an occupation or profession regulated under this title
             464bt      beyond the scope of the licensee's license;
             464bu          (k) verbally, physically, mentally, or sexually abusing or exploiting any person through
             464bv      conduct connected with the licensee's practice under this title or otherwise facilitated by the
             464bw      licensee's license; or
             464bx          (l) acting as a supervisor without meeting the qualification requirements for that position that
             464by      are defined by statute or rule[.]; OR
             464bz          (m) UNLESS SUBSECTION (3) APPLIES, ISSUING, OR AIDING AND ABETTING IN THE


             464ca      ISSUANCE OF, AN ORDER OR PRESCRIPTION FOR A DRUG OR DEVICE:
             464cb          (i) WITHOUT FIRST OBTAINING INFORMATION IN THE USUAL COURSE OF PROFESSIONAL
             464cc      PRACTICE, THAT IS SUFFICIENT TO ESTABLISH A DIAGNOSIS, TO IDENTIFY CONDITIONS, AND TO
             464cd      IDENTIFY CONTRAINDICATIONS TO THE PROPOSED TREATMENT; OR
             464ce          (ii) BASED ON A QUESTIONNAIRE COMPLETED BY THE PATIENT ON THE INTERNET, OR
             464cf      TOLL FREE TELEPHONE NUMBER WHEN THERE EXISTS NO OTHER s


            
Text Box

- 16b -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
464cg
     S BONAFIDE PATIENT-PRACTITIONER RELATIONSHIP OR BONA FIDE REFERRAL BY A
             464ch      PRACTITIONER INVOLVED IN AN EXISTING PATIENT-PRACTITIONER RELATIONSHIP.
             464ci          (c) SUBSECTIONS (2)(m)(i) AND (ii) DO NOT APPLY TO TREATMENT RENDERED IN AN
             464cj      EMERGENCY, ON-CALL, OR CROSS COVERAGE SITUATION.
             464ck          (3) NOTWITHSTANDING SUBSECTIONS (1)(f) AND (2)(m), THE DIVISION MAY PERMIT A
             464cl      PERSON LICENSED TO PRESCRIBE UNDER THIS TITLE TO PRESCRIBE A LEGEND DRUG TO A
             464cm      PERSON LOCATED IN THIS STATE IF THE DIVISION IN COLLABORATION WITH THE APPROPRIATE
             464cn      PROFESSIONAL BOARD HAS PERMITTED THE SPECIFIC PRESCRIPTIVE PRACTICE OF THE LEGEND
             464co      DRUG BY RULE. s
             465           58-16a-102. Definitions.
             466          In addition to the definitions in Section 58-1-102 , as used in this chapter:
             467          (1) "Board" means the Optometrist Licensing Board created in Section 58-16a-201 .
             468          (2) "Contact lens" means any lens that:
             469          (a) has a spherical, cylindrical, or prismatic power or curvature;
             470          (b) is made pursuant to a current prescription; or
             471          (c) is intended to be worn on the surface of the eye.
             472          (3) (a) "Contact lens prescription" means a written or verbal order for contact lenses
             473      that includes:
             474          (i) the commencement date of the prescription;
             475          (ii) the base curve, power, diameter, material or brand name, and expiration date;
             476          (iii) for a written order, the signature of the prescribing optometrist or physician; and
             477          (iv) for a verbal order, a record maintained by the recipient of:
             478          (A) the name of the prescribing optometrist or physician; and
             479          (B) the date when the prescription was issued or ordered.
             480          (b) A prescription may include:
             481          (i) a limit on the quantity of lenses that may be ordered under the prescription if
             482      required for medical reasons documented in the patient's files; and
             483          (ii) the expiration date of the prescription, which shall be two years from the
             484      commencement date, unless documented medical reasons require otherwise.
             485          (c) When a provider prescribes a private label contact lens for a patient the prescription
             486      shall include:
             487          (i) the name of the manufacturer;
             488          (ii) the trade name of the private label brand; and
             489          (iii) if applicable, the trade name of the equivalent national brand.
             490          (4) "Contact lens prescription verification" means a written request from a person who
             491      sells contact lenses that:
             492          (a) is sent to the prescribing optometrist or physician; and




Text Box

- 17 -
             493
         (b) seeks the confirmation of the accuracy of a patient's prescription.
             494          (5) "Eye and its adnexa" means the human eye and all structures situated within the
             495      orbit, including the conjunctiva, lids, lashes, and lacrimal system.
             496          (6) "Fitting of a contact lens" means:
             497          (a) the using of a keratometer to measure the human eye;
             498          (b) utilizing refractive data provided by a licensed optometrist or ophthalmologist; and
             499          (c) trial fitting of contact lenses, which includes a period of time for evaluation for fit
             500      and performance, to determine a tentative contact lens prescription for a patient if the patient:
             501          (i) has not worn contact lenses before; or
             502          (ii) has changed to a different type or base curve.
             503          (7) "Laser surgery" means surgery in which human tissue is cut, burned, or vaporized
             504      by means of laser or ionizing radiation.
             505          (8) "Ophthalmic lens" means any lens used to treat the eye and that:
             506          (a) has a spherical, cylindrical, or prismatic power;
             507          (b) is made pursuant to an unexpired prescription; and
             508          (c) is intended to be used in eyeglasses or spectacles.
             509          (9) "Optometric assistant" means an unlicensed individual:
             510          (a) working under the direct and immediate supervision of a licensed optometrist; and
             511          (b) engaged in specific tasks assigned by the licensed optometrist in accordance with
             512      the standards and ethics of the profession.
             513          (10) "Optometrist" or "optometric physician" means an individual licensed under this
             514      chapter.
             515          (11) "Optometry" and "practice of optometry" mean any one or any combination of the
             516      following practices:
             517          (a) examination of the human eye and its adnexa to detect and diagnose defects or
             518      abnormal conditions;
             519          (b) determination or modification of the accommodative or refractive state of the
             520      human eye or its range or power of vision by administration and prescription of pharmaceutical
             521      agents or the use of diagnostic instruments;
             522          (c) prescription, ordering, administration, or adaptation of ophthalmic lenses, contact
             523      lenses, ophthalmic devices, pharmaceutical agents, laboratory tests, or ocular exercises to



Text Box

- 18 -
             524
     diagnose and treat diseases, defects, or other abnormal conditions of the human eye and its
             525      adnexa;
             526          (d) display of any advertisement, circular, sign, or device offering to:
             527          (i) examine the eyes;
             528          (ii) fit glasses or contact lenses; or
             529          (iii) adjust frames;
             530          (e) removal of a foreign body from the eye or its adnexa, that is not deeper than the
             531      anterior 1/2 of the cornea;
             532          (f) consultation regarding the eye and its adnexa with other appropriate health care
             533      providers, including referral to other appropriate health care providers; and
             534          (g) a person, not licensed as an optometrist, directing a licensee under this chapter to
             535      withhold or alter the eye care services the licensee has ordered.
             536          (12) "Pharmaceutical agent" means any diagnostic or therapeutic drug or combination
             537      of drugs that has the property of assisting in the diagnosis, prevention, treatment, or mitigation
             538      of abnormal conditions or symptoms of the eye and its adnexa.
             539          (13) "Physician" has the same meaning as defined in Subsection 58-67-102 (7).
             540          (14) "Prescription drug" has the same definition as in Section [ 58-17a-102 ]
             541      58-17b-102 .
             542          (15) "Unexpired" means a prescription that was issued:
             543          (a) not more than two years prior to presentation of the prescription for an ophthalmic
             544      lens; or
             545          (b) in accordance with Subsection (3) for a contact lens.
             546          Section 8. Section 58-17b-101 is enacted to read:
             547     
CHAPTER 17b. PHARMACY PRACTICE ACT

             548     
Part 1. General Provisions

             549          58-17b-101. Title.
             550          This chapter is known as the "Pharmacy Practice Act."
             551          Section 9. Section 58-17b-102 is enacted to read:
             552          58-17b-102. Definitions.
             553          In addition to the definitions in Section 58-1-102 , as used in this chapter:
             554          (1) "Administering" means:



Text Box

- 19 -
             555
         (a) the direct application of a prescription drug or device, whether by injection,
             556      inhalation, ingestion, or by any other means, to the body of a human patient or research subject
             557      by another person; or
             558          (b) the placement by a veterinarian with the owner or caretaker of an animal or group
             559      of animals of a prescription drug for the purpose of injection, inhalation, ingestion, or any other
             560      means directed to the body of the animal by the owner or caretaker in accordance with written
             561      or verbal directions of the veterinarian.
             562          (2) "Adulterated drug or device" means a drug or device considered adulterated under
             563      21 U.S.C.S. Sec. 351 (2003).
             564          (3) (a) "Analytical laboratory" means a facility in possession of prescription drugs for
             565      the purpose of analysis.
             566          (b) "Analytical laboratory" does not include a laboratory possessing prescription drugs
             567      used as standards and controls in performing drug monitoring or drug screening analysis if the
             568      prescription drugs are prediluted in a human or animal body fluid, human or animal body fluid
             569      components, organic solvents, or inorganic buffers at a concentration not exceeding one
             570      milligram per milliliter when labeled or otherwise designated as being for in vitro diagnostic
             571      use.
             572          (4) "Animal euthanasia agency" means an agency performing euthanasia on animals by
             573      the use of prescription drugs.
             574          (5) "Automated pharmacy systems" includes mechanical systems which perform
             575      operations or activities, other than compounding or administration, relative to the storage,
             576      packaging, dispensing, or distribution of medications, and which collect, control, and maintain
             577      all transaction information.
             578          (6) "Beyond-use-date" means a date determined by a pharmacist and should be placed
             579      on a prescription label at the time of dispensing that is intended to indicate to the patient or
             580      caregiver a time beyond which the contents of the prescription are not recommended to be
             581      used.
             582          (7) "Branch pharmacy" means a pharmacy or other facility in a rural or medically
             583      underserved area, used for the storage and dispensing of prescription drugs, which is dependent
             584      upon, stocked by, and supervised by a pharmacist in another licensed pharmacy designated and
             585      approved by the division as the parent pharmacy.



Text Box

- 20 -
             586
         (8) "Board of pharmacy" or "board" means the Utah State Board of Pharmacy as
             587      created in Section 58-17b-201 .
             588          (9) "Centralized prescription processing" means the processing by a pharmacy of a
             589      request from another pharmacy to fill or refill a prescription drug order or to perform
             590      processing functions such as dispensing, drug utilization review, claims adjudication, refill
             591      authorizations, and therapeutic interventions.
             592          (10) "Class A pharmacy" means a pharmacy that is authorized as a retail pharmacy to
             593      compound or dispense a drug or dispense a device to the public under a prescription order.
             594          (11) "Class B pharmacy" means a pharmacy that is authorized to provide
             595      pharmaceutical care for patients in an institutional setting and whose primary purpose is to
             596      provide a physical environment for patients to obtain health care services and includes closed
             597      door, hospital, clinics, nuclear, branch, pharmaceutical research facilities, pharmaceutical
             598      administration facilities, and sterile product preparation facilities.
             599          (12) "Class C pharmacy" means a pharmacy that is authorized to engage in the
             600      manufacture, production, wholesale, or distribution of drugs or devices.
             601          (13) "Class D pharmacy" means a nonresident pharmacy to include any pharmacy
             602      outside of Utah that is authorized to deliver drugs or devices to residents of Utah.
             603          (14) "Class E pharmacy" means all other pharmacy facilities.
             604          (15) "Closed door" pharmacy means a pharmacy that provides pharmaceutical care to a
             605      defined and exclusive group of patients who have access to the services of the pharmacy
             606      because they are treated by or have an affiliation with a specific entity including health
             607      maintenance organizations and infusion companies, and does not include hospital pharmacies,
             608      retail sales to the general public, or the offices of practitioners.
             609          (16) "Collaborative pharmacy practice" means a practice of pharmacy whereby one or
             610      more pharmacists have jointly agreed, on a voluntary basis, to work in conjunction with one or
             611      more practitioners under protocol whereby the pharmacist may perform certain pharmaceutical
             612      care functions authorized by the practitioner or practitioners under certain specified conditions
             613      or limitations.
             614          (17) "Collaborative pharmacy practice agreement" means a written and signed
             615      agreement between one or more pharmacists and one or more practitioners that provides for
             616      collaborative pharmacy practice for the purpose of drug therapy management of patients and



Text Box

- 21 -
             617
     prevention of disease of human subjects.
             618          (18) (a) "Compounding" means the preparation, mixing, assembling, packaging, or
             619      labeling of a limited quantity drug, sterile product, or device:
             620          (i) as the result of a practitioner's prescription order or initiative based on the
             621      practitioner, patient, or pharmacist relationship in the course of professional practice;
             622          (ii) for the purpose of, or as an incident to, research, teaching, or chemical analysis and
             623      not for sale or dispensing; or
             624          (iii) in anticipation of prescription drug orders based on routine, regularly observed
             625      prescribing patterns.
             626          (b) "Compounding" does not include:
             627          (i) the preparation of prescription drugs by a pharmacist or pharmacy intern for sale to
             628      another pharmacist or pharmaceutical administration facility;
             629          (ii) the preparation by a pharmacist or pharmacy intern of any prescription drug in a
             630      dosage form which is regularly and commonly available from a manufacturer in quantities and
             631      strengths prescribed by a practitioner; or
             632          (iii) the preparation of a prescription drug, sterile product, or device which has been
             633      withdrawn from the market for safety reasons.
             634          (19) "Confidential information" has the same meaning as "protected health
             635      information" under the Standards for Privacy of Individually Identifiable Health Information,
             636      45 C.F.R. Parts 160 and 164.
             637          (20) "Controlled substance" has the same definition as in Section 58-37-2 .
             638          (21) "Device" means an instrument, apparatus, implement, machine, contrivance,
             639      implant, in vitro reagent, or other similar or related article, including any component part or
             640      accessory, which is required under federal or state law to be prescribed by a practitioner and
             641      dispensed by a pharmacist or pharmacy intern.
             642          (22) "Dietary supplement" has the same meaning as Public Law Title 103, Chapter
             643      417, Sec. 3a(ff) which is incorporated by reference.
             644          (23) "Dispense" means the interpretation, evaluation, and implementation of a
             645      prescription drug order or device or nonprescription drug or device under a lawful order of a
             646      practitioner in a suitable container appropriately labeled for subsequent administration to or use
             647      by a patient, research subject, or an animal.



Text Box

- 22 -
             648
         (24) "Distribute" means to deliver a drug or device other than by administering or
             649      dispensing.
             650          (25) "Drug" means:
             651          (a) a substance recognized as a drug in any official compendium, or supplement
             652      thereto, designated from time to time by the division in collaboration with the board for use in
             653      the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or animals,
             654      excluding nonprescription drugs or dietary supplements;
             655          (b) a drug or device that is required by any applicable federal or state law or rule to be
             656      dispensed on prescription only or is restricted to use by practitioners only;
             657          (c) substances other than food intended to affect the structure or any function of the
             658      body of humans or other animals, excluding nonprescription dietary supplements; and
             659          (d) substances intended for use as a component of any substance specified in
             660      Subsection (25)(a), (b), or (c).
             661          (26) "Drug product equivalent" means a drug product that is designated as the
             662      therapeutic equivalent of another drug product in the Approved Drug Products with
             663      Therapeutic Equivalence Evaluations prepared by the Center for Drug Evaluation and Research
             664      of the Federal Food and Drug Administration.
             665          (27) "Drug regimen review" includes the following activities:
             666          (a) evaluation of the prescription drug order and patient record for:
             667          (i) known allergies;
             668          (ii) rational therapy-contraindications;
             669          (iii) reasonable dose and route of administration; and
             670          (iv) reasonable directions for use;
             671          (b) evaluation of the prescription drug order and patient record for duplication of
             672      therapy;
             673          (c) evaluation of the prescription drug order and patient record for interactions:
             674          (i) drug-drug;
             675          (ii) drug-food;
             676          (iii) drug-disease; and
             677          (iv) adverse drug reactions; and
             678          (d) evaluation of the prescription drug order and patient record for proper utilization,



Text Box

- 23 -
             679
     including over- or under-utilization, and optimum therapeutic outcomes.
             680          (28) "Drug sample" means a prescription drug packaged in small quantities consistent
             681      with limited dosage therapy of the particular drug, which is marked "sample", is not intended to
             682      be sold, and is intended to be provided to practitioners for the immediate needs of patients for
             683      trial purposes or to provide the drug to the patient until a prescription can be filled by the
             684      patient.
             685          (29) "Electronic signature" means a trusted, verifiable, and secure electronic sound,
             686      symbol, or process attached to or logically associated with a record and executed or adopted by
             687      a person with the intent to sign the record.
             688          (30) "Electronic transmission" means transmission of information in electronic form or
             689      the transmission of the exact visual image of a document by way of electronic equipment.
             690          (31) "Extern" means a college of pharmacy student enrolled in a college coordinated
             691      practical experience program in a health care setting under the supervision of a preceptor, as
             692      defined in this act, and approved by a college of pharmacy.
             693          (32) "Hospital pharmacy" means a pharmacy providing pharmaceutical care to
             694      inpatients of a general acute hospital or specialty hospital licensed by the Department of Health
             695      under Title 26, Chapter 21, Health Care Facility Licensing and Inspection Act.
             696          (33) "Licensed pharmacy technician" means an individual licensed with the division,
             697      that may, under the supervision of a pharmacist, perform the activities involved in the
             698      technician practice of pharmacy.
             699          (34) "Manufacturer" means a person or business physically located in Utah licensed to
             700      be engaged in the manufacturing of drugs or devices.
             701          (35) (a) "Manufacturing" means:
             702          (i) the production, preparation, propagation, conversion, or processing of a drug or
             703      device, either directly or indirectly, by extraction from substances of natural origin or
             704      independently by means of chemical or biological synthesis, or by a combination of extraction
             705      and chemical synthesis, and includes any packaging or repackaging of the substance or labeling
             706      or relabeling of its container; and
             707          (ii) the promotion and marketing of such drugs or devices.
             708          (b) "Manufacturing" includes the preparation and promotion of commercially available
             709      products from bulk compounds for resale by pharmacies, practitioners, or other persons.



Text Box

- 24 -
Senate 3rd Reading Amendments 2-24-2004 rd/cjd
             710
         (c) "Manufacturing" does not include the preparation or compounding of a drug by a
             711      pharmacist, pharmacy intern, or practitioner for that individual's own use or the preparation,
             712      compounding, packaging, labeling of a drug, or incident to research, teaching, or chemical
             713      analysis.
             714          (36) "Medical order" means a lawful order of a practitioner which may include a
             715      prescription drug order.
             716          (37) "Medication profile" or "profile" means a record system maintained as to drugs or
             717      devices prescribed for a pharmacy patient to enable a pharmacist or pharmacy intern to analyze
             718      the profile to provide pharmaceutical care.
             719          (38) "Misbranded drug or device" means a drug or device considered misbranded under
             720      21 U.S.C.S. Sec. 352 (2003).
             721          (39) "Nonprescription drug" means a drug which may be sold without a prescription
             722      and which is labeled for use by the consumer in accordance with federal law and includes
             723      homeopathic remedies.
             724          (40) "Nonresident pharmacy" means any pharmacy that sells to anyone in Utah, but is
             725      not physically located in Utah.
             726          (41) "Nuclear pharmacy" means a pharmacy providing radio-pharmaceutical service.
             727          (42) "Out-of-state mail service pharmacy" means a pharmaceutical facility located
             728      outside the state that S IS LICENSED AND IN GOOD STANDING IN ANOTHER STATE, THAT s :
             729          (a) ships, mails, or delivers by any lawful means a dispensed legend drug to a resident
             730      in this state pursuant to a legally issued prescription;
             731          (b) provides information to a resident of this state on drugs or devices which may
             732      include, but is not limited to, advice relating to therapeutic values, potential hazards, and uses;
             733      or
             734          (c) counsels pharmacy patients residing in this state concerning adverse and therapeutic
             735      effects of drugs.
             736          (43) "Patient counseling" means the written and oral communication by the pharmacist,
             737      pharmacy preceptor, or pharmacy intern of information, to the patient or caregiver, in order to
             738      ensure proper use of drugs, devices, and dietary supplements.
             739          (44) "Pharmaceutical administration facility" means a health care facility or agency, in
             740      which:



Text Box


- 25 -

             741
         (a) prescription drugs or devices are held, stored, or are otherwise under the control of
             742      the facility or agency for administration to patients of that facility or agency;
             743          (b) prescription drugs are dispensed to the facility or agency by a licensed pharmacist
             744      or pharmacy intern with whom the facility has established a prescription drug supervising
             745      relationship under which the pharmacist or pharmacy intern provides counseling to the facility
             746      or agency staff as required, and oversees drug control, accounting, and destruction; and
             747          (c) prescription drugs are professionally administered in accordance with the order of a
             748      practitioner by an employee or agent of the facility or agency.
             749          (45) (a) "Pharmaceutical care" means carrying out the following in collaboration with a
             750      prescribing practitioner, and in accordance with division rule:
             751          (i) designing, implementing, and monitoring a therapeutic drug plan intended to
             752      achieve favorable outcomes related to a specific patient for the purpose of curing or preventing
             753      the patient's disease;
             754          (ii) eliminating or reducing a patient's symptoms; or
             755          (iii) arresting or slowing a disease process.
             756          (b) "Pharmaceutical care" does not include prescribing of drugs without consent of a
             757      prescribing practitioner.
             758          (46) "Pharmaceutical facility" means a business engaged in the dispensing, delivering,
             759      distributing, manufacturing, or wholesaling of prescription drugs or devices within or into this
             760      state.
             761          (47) (a) "Pharmaceutical research facility" means a facility engaged in conducting
             762      scientific research regarding drugs and their use in accordance with standard research protocols
             763      and techniques, who maintains competent documentation with respect to the research, and who
             764      uses prescription drugs in the conduct of the research.
             765          (b) "Pharmaceutical research facility" does not include any licensed facility or clinic
             766      whose primary researchers are licensed practitioners.
             767          (48) (a) "Pharmaceutical wholesaler or distributor" means a pharmaceutical facility
             768      engaged in the business of wholesale vending or selling of any prescription drug or device to
             769      other than the consumer or user of the prescription drug or device, which the pharmaceutical
             770      facility has not produced, manufactured, compounded, or dispensed.
             771          (b) "Pharmaceutical wholesaler or distributor" does not include a pharmaceutical



Text Box

- 26 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
             772
     facility carrying out the following business activities:
             773          (i) intracompany sales;
             774          (ii) the sale, purchase, or trade of a prescription drug or device, or offer to sell,
             775      purchase or trade a prescription drug or device between hospitals or other health care facilities
             776      that are under common ownership or control of the management and operation of the facilities;
             777          (iii) the sale, purchase, or trade of a prescription drug or device, or offer to sell,
             778      purchase, or trade a prescription drug or device for emergency medical reasons, or to supply
             779      another pharmaceutical facility to alleviate a temporary shortage; or
             780          (iv) the distribution of a prescription drug or device as a sample by representatives of a
             781      manufacturer.
             782          (49) "Pharmacist" means an individual licensed by this state to engage in the practice
             783      of pharmacy.
             784          (50) "Pharmacist-in-charge" means a pharmacist currently licensed in good standing
             785      who accepts responsibility for the operation of a pharmacy in conformance with all laws and
             786      rules pertinent to the practice of pharmacy and the distribution of drugs, and who is personally
             787      in full and actual charge of the pharmacy and all personnel.
             788          (51) "Pharmacist preceptor" means a licensed pharmacist in good standing with two or
             789      more years of licensed experience whose name appears on a division list of approved
             790      preceptors. The preceptor serves as a teacher, example of professional conduct, and supervisor
             791      of interns in the professional practice of pharmacy.
             792          (52) "Pharmacy" means any place within Utah where drugs are dispensed and
             793      pharmaceutical care is provided and any place outside of Utah where drugs are dispensed and
             794      pharmaceutical care is provided to residents of Utah.
             795          (53) "Pharmacy benefits manager or coordinator" means a person S OR ENTITY s that
             795a      administers the
             796      prescription drug or device portion of health insurance plans on behalf of plan sponsors, such
             797      as self-insured employers, insurance companies, and health maintenance organizations, and
             798      may be further defined by rule.
             799          (54) "Pharmacy intern" means an individual licensed by this state to engage in practice
             800      as a pharmacy intern.
             801          (55) "Pharmacy technician training program" means an approved technician training
             802      program providing education for pharmacy technicians.



Text Box

- 27 -
             803
         (56) (a) "Practice as a licensed pharmacy technician" means engaging in practice as a
             804      pharmacy technician under the general supervision of a licensed pharmacist and in accordance
             805      with a scope of practice as defined by division rule made in collaboration with the board.
             806          (b) "Practice as a licensed pharmacy technician" does not include:
             807          (i) performing a drug utilization review, prescription drug order clarification from a
             808      prescriber, final review of the prescription and prescribed drug prepared for dispensing,
             809      dispensing of the drug, or counseling a patient with respect to a prescription drug;
             810          (ii) counseling regarding nonprescription drugs and dietary supplements unless
             811      delegated by the supervising pharmacist; or
             812          (iii) receiving new prescription drug orders when communicating telephonically or
             813      electronically unless the original information is recorded so the pharmacist may review the
             814      prescription drug order as transmitted.
             815          (57) "Practice of pharmacy" includes the following:
             816          (a) providing pharmaceutical care;
             817          (b) collaborative pharmacy practice in accordance with a collaborative pharmacy
             818      practice agreement;
             819          (c) compounding, packaging, labeling, dispensing, administering, and the coincident
             820      distribution of prescription drugs or devices, provided that the administration of a prescription
             821      drug or device is:
             822          (i) pursuant to a lawful order of a practitioner when one is required by law; and
             823          (ii) in accordance with written guidelines or protocols:
             824          (A) established by the licensed facility in which the prescription drug or device is to be
             825      administered on an inpatient basis; or
             826          (B) approved by the division, in collaboration with the board and the Physician's
             827      Licensing Board, created in Section 58-67-201 , if the prescription drug or device is to be
             828      administered on an outpatient basis solely by a licensed pharmacist;
             829          (d) participating in drug utilization review;
             830          (e) ensuring proper and safe storage of drugs and devices;
             831          (f) maintaining records of drugs and devices in accordance with state and federal law
             832      and the standards and ethics of the profession;
             833          (g) providing information on drugs or devices, which may include advice relating to



Text Box

- 28 -
             834
     therapeutic values, potential hazards, and uses;
             835          (h) providing drug product equivalents;
             836          (i) supervising pharmacist's supportive personnel, pharmacy interns, and pharmacy
             837      technicians;
             838          (j) providing patient counseling, including adverse and therapeutic effects of drugs;
             839          (k) providing emergency refills as defined by rule;
             840          (l) telepharmacy; and
             841          (m) formulary management intervention.
             842          (58) "Practice of telepharmacy" means the practice of pharmacy through the use of
             843      telecommunications and information technologies.
             844          (59) "Practice of telepharmacy across state lines" means the practice of pharmacy
             845      through the use of telecommunications and information technologies that occurs when the
             846      patient is physically located within one jurisdiction and the pharmacist is located in another
             847      jurisdiction.
             848          (60) "Practitioner" means an individual currently licensed, registered, or otherwise
             849      authorized by the appropriate jurisdiction to prescribe and administer drugs in the course of
             850      professional practice.
             851          (61) "Prescription" means an order:
             852          (a) issued by a licensed practitioner:
             853          (i) orally, in writing, by telephone, facsimile transmission, computer, or other
             854      electronic means of communication as defined by division rule;
             855          (ii) in the course of the practitioner's professional practice; or
             856          (iii) by collaborative pharmacy practice agreement; and
             857          (b) for a controlled substance, other prescription drug, or device with the intent that the
             858      controlled substance, prescription drug, or device will be used by a patient or an animal.
             859          (62) "Prescription drug or device" means:
             860          (a) a legend drug or device; or
             861          (b) a drug or device that is required by an applicable federal or state law or rule to be
             862      dispensed on prescription only or is restricted to use by practitioners only.
             863          (63) "Retail pharmacy" means a pharmaceutical facility dispensing prescription drugs
             864      and devices to the general public.



Text Box

- 29 -
             865
         (64) "Self-audit" means an internal evaluation of a pharmacy to determine compliance
             866      with this chapter.
             867          (65) "Supervising pharmacist" means a pharmacist who is overseeing the operation of
             868      the pharmacy during a given day or shift.
             869          (66) "Supportive personnel" means unlicensed individuals who:
             870          (a) may assist a pharmacist, pharmacist preceptor, pharmacy intern, or licensed
             871      pharmacy technician in nonjudgmental duties not included in the definition of the practice of
             872      pharmacy, practice of a pharmacy intern, or practice of a licensed pharmacy technician, and as
             873      those duties may be further defined by division rule adopted in collaboration with the board;
             874      and
             875          (b) are supervised by a pharmacist in accordance with rules adopted by the division in
             876      collaboration with the board.
             877          (67) "Unlawful conduct" is as defined in Sections 58-1-501 and 58-17b-501 .
             878          (68) "Unprofessional conduct" is as defined in Sections 58-1-501 and 58-17b-502 and
             879      may be further defined by rule.
             880          (69) "Veterinary pharmaceutical facility" means a pharmaceutical facility that
             881      dispenses drugs intended for use by animals or for sale to veterinarians for the administration
             882      for animals.
             883          Section 10. Section 58-17b-103 is enacted to read:
             884          58-17b-103. Administrative inspections.
             885          (1) The division may for the purpose of ascertaining compliance with the provisions of
             886      this chapter, require a self-audit or enter and inspect the business premises of a person:
             887          (a) licensed under Part 3, Licensing; or
             888          (b) who is engaged in activities that require a license under Part 3, Licensing.
             889          (2) Before conducting an inspection under Subsection (1), the division shall, after
             890      identifying the person in charge:
             891          (a) give proper identification;
             892          (b) request to see the applicable license or licenses;
             893          (c) describe the nature and purpose of the inspection; and
             894          (d) provide upon request, the authority of the division to conduct the inspection and the
             895      penalty for refusing to permit the inspection as provided in Section 58-17b-504 .



Text Box

- 30 -
             896
         (3) In conducting an inspection under Subsection (1), the division may, after meeting
             897      the requirements of Subsection (2):
             898          (a) examine any record, prescription, order, drug, device, equipment, machine,
             899      electronic device or media, or area related to activities for which a license has been issued or is
             900      required by Part 3, Licensing, for the purpose of ascertaining compliance with the applicable
             901      provisions of this chapter;
             902          (b) take a drug or device for further analysis if considered necessary;
             903          (c) temporarily seize a drug or device which is suspected to be adulterated, misbranded,
             904      outdated, or otherwise in violation of this chapter, pending an adjudicative proceeding on the
             905      matter;
             906          (d) box and seal drugs suspected to be adulterated, outdated, misbranded, or otherwise
             907      in violation of this chapter; and
             908          (e) dispose of or return any drug or device obtained under this Subsection (3) in
             909      accordance with procedures established by division rule.
             910          (4) An inspection conducted under Subsection (1) shall be during regular business
             911      hours.
             912          (5) If upon inspection, the division concludes that a person has violated the provisions
             913      of this chapter or Chapter 37, Utah Control Substances Act, or any rule or order issued with
             914      respect to those chapters, and that disciplinary action is appropriate, the director or the
             915      director's designee shall promptly issue a fine or citation to the licensee in accordance with
             916      Section 58-17b-504 .
             917          Section 11. Section 58-17b-201 is enacted to read:
             918     
Part 2. Board

             919          58-17b-201. Board -- Membership -- Qualifications -- Terms.
             920          (1) There is created the Utah State Board of Pharmacy consisting of five pharmacists,
             921      one pharmacy technician, and one member of the general public.
             922          (a) The public member of the board shall be a Utah resident who:
             923          (i) is 21 years of age or older;
             924          (ii) has never been licensed to engage in the practice of pharmacy;
             925          (iii) has never been the spouse of a person licensed to engage in the practice of
             926      pharmacy;



Text Box

- 31 -
             927
         (iv) has never held any material financial interest in pharmacy practice; and
             928          (v) has never engaged in any activity directly related to the practice of pharmacy.
             929          (b) The licensed pharmacist and licensed pharmacy technician members of the board
             930      shall:
             931          (i) have been Utah residents continuously for at least three years;
             932          (ii) have at least five years experience in the practice of pharmacy in good standing
             933      with the division in Utah after licensure; and
             934          (iii) maintain licensure in good standing to engage in the practice of pharmacy or
             935      practice as a pharmacy technician in Utah for the duration of the appointment.
             936          (2) The board shall be appointed and serve in accordance with Section 58-1-201 .
             937          (3) The duties and responsibilities of the board are in accordance with Sections
             938      58-1-202 and 58-1-203 . In addition, the board shall designate an appropriate member on a
             939      permanent or rotating basis to:
             940          (a) assist the division in reviewing complaints concerning the unlawful or
             941      unprofessional conduct of a licensee; and
             942          (b) advise the division in its investigation of these complaints.
             943          (4) A board member who has, under Subsection (3), reviewed a complaint or advised
             944      in its investigation may be disqualified from participating with the board when the board serves
             945      as a presiding officer in an adjudicative proceeding concerning the complaint.
             946          (5) A board member may be removed in accordance with Subsection 58-1-201 (2)(e) or
             947      upon one of the following grounds:
             948          (a) refusal or inability for any reason of a board member to perform his duties as a
             949      member of the Board in an efficient, responsible, and professional manner;
             950          (b) misuse of appointment to obtain personal, pecuniary, or material gain or advantage
             951      for himself or another through such appointment; or
             952          (c) violation of the laws governing the practice of pharmacy or Chapter 37, Utah
             953      Controlled Substances Act.
             954          Section 12. Section 58-17b-301 is enacted to read:
             955     
Part 3. Licensing

             956          58-17b-301. License required -- License classifications for individuals.
             957          (1) A license is required to engage in the practice of pharmacy, telepharmacy, or the



Text Box

- 32 -
             958
     practice of a pharmacy technician, except as specifically provided in Section 58-1-307 or
             959      58-17b-309 .
             960          (2) The division shall issue to an individual who qualifies under this chapter a license
             961      in the classification of:
             962          (a) pharmacist;
             963          (b) pharmacy intern; or
             964          (c) pharmacy technician.
             965          Section 13. Section 58-17b-302 is enacted to read:
             966          58-17b-302. License classifications of pharmacy facilities.
             967          (1) A license is required to act as a pharmacy, except as specifically exempted from
             968      licensure under Section 58-1-307 .
             969          (2) The division shall issue a pharmacy license to a facility that qualifies under this
             970      chapter in the classification of a:
             971          (a) class A pharmacy;
             972          (b) class B pharmacy;
             973          (c) class C pharmacy;
             974          (d) class D pharmacy; or
             975          (e) class E pharmacy.
             976          (3) Each place of business shall require a separate license. If multiple pharmacies exist
             977      at the same address, a separate license shall be required for each pharmacy.
             978          (4) The division may further define or supplement the classifications of pharmacies.
             979      The division may impose restrictions upon classifications to protect the public health, safety,
             980      and welfare.
             981          (5) Each pharmacy shall have a pharmacist-in-charge, except as otherwise provided by
             982      rule.
             983          (6) Whenever an applicable statute or rule requires or prohibits action by a pharmacy,
             984      the pharmacist-in-charge and the owner or owners of the pharmacy shall be responsible for all
             985      activities of the pharmacy, regardless of the form of the business organization.
             986          (7) Any facility holding a pharmacy license prior to July 1, 2004, shall be converted
             987      from the classification of license currently held to the appropriate classification established
             988      under this chapter upon their next renewal or reinstatement of licensure, in accordance with a



Text Box

- 33 -
             989
     conversion schedule established by rule.
             990          Section 14. Section 58-17b-303 is enacted to read:
             991          58-17b-303. Qualifications for licensure as a pharmacist.
             992          (1) Each applicant for licensure as a pharmacist shall:
             993          (a) submit an application in a form prescribed by the division;
             994          (b) pay a fee as determined by the department under Section 63-38-3.2 ;
             995          (c) produce satisfactory evidence of good moral character as it relates to the applicant's
             996      ability to practice pharmacy;
             997          (d) complete a criminal background check and be free from criminal convictions as
             998      required by Section 58-17b-307 , or as described in Section 58-1-501 ;
             999          (e) have no physical or mental condition of a nature which prevents the applicant from
             1000      engaging in the practice of pharmacy with reasonable skill, competency, and safety to the
             1001      public;
             1002          (f) have graduated and received a professional entry degree from a school or college of
             1003      pharmacy which is accredited by the American Council on Pharmaceutical Education;
             1004          (g) have completed an internship meeting standards established by division rule made
             1005      in collaboration with the board; and
             1006          (h) have successfully passed examinations required by division rule made in
             1007      collaboration with the board.
             1008          (2) Each applicant for licensure as a pharmacist whose pharmacy education was
             1009      completed at a foreign pharmacy school shall, in addition to the requirements under
             1010      Subsections (1)(a) through (e), (g), and (h), obtain a certification of equivalency from a
             1011      credentialing agency required by division rule made in collaboration with the board.
             1012          (3) Each applicant for a license by endorsement as a pharmacist under this section
             1013      shall:
             1014          (a) submit a written application in the form prescribed by the division;
             1015          (b) pay the fee determined by the department under Section 63-38-3.2 ;
             1016          (c) be of good moral character as required of applicants for licensure as pharmacists
             1017      under Subsection (1);
             1018          (d) complete a criminal background check and be free from criminal convictions as
             1019      required by Section 58-17b-307 , or as otherwise described in Section 58-1-501 ;



Text Box

- 34 -
             1020
         (e) have no physical or mental condition of a nature which prevents the applicant from
             1021      engaging in the practice of pharmacy with reasonable skill, competency, and safety to the
             1022      public;
             1023          (f) have lawfully practiced as a licensed pharmacist a minimum of 2,000 hours in the
             1024      four years immediately preceding the date of application;
             1025          (g) produce satisfactory evidence of completing the professional education required
             1026      under Subsection (1);
             1027          (h) be currently licensed in good standing as a pharmacist in another state, territory, or
             1028      possession of the United States;
             1029          (i) produce satisfactory evidence that the examination requirements are or were at the
             1030      time the license was issued, equal to those of this state; and
             1031          (j) pass the jurisprudence examination prescribed by division rule made in
             1032      collaboration with the board.
             1033          Section 15. Section 58-17b-304 is enacted to read:
             1034          58-17b-304. Qualifications for licensure of pharmacy intern.
             1035          Each applicant for licensure as a pharmacy intern shall:
             1036          (1) submit an application in a form prescribed by the division;
             1037          (2) pay a fee determined by the department under Section 63-38-3.2 ;
             1038          (3) produce satisfactory evidence of good moral character as it relates to the applicant's
             1039      ability to practice pharmacy;
             1040          (4) complete a criminal background check and be free from criminal convictions as
             1041      required by Section 58-17b-307 , or as otherwise described in Section 58-1-501 ;
             1042          (5) have no physical or mental condition of a nature which prevents the applicant from
             1043      engaging in the practice of pharmacy with reasonable skill, competency, and safety to the
             1044      public;
             1045          (6) meet the preliminary educational qualifications required by division rule made in
             1046      collaboration with the board; and
             1047          (7) meet one of the following educational criteria:
             1048          (a) be a current pharmacy student, a resident, or fellow in a program approved by
             1049      division rule in collaboration with the board;
             1050          (b) have graduated and received a pharmacy degree from a school or college of



Text Box

- 35 -
             1051
     pharmacy which is accredited by the American Council on Pharmaceutical Education; or
             1052          (c) have graduated from a foreign pharmacy school and received certification of
             1053      equivalency from a credentialing agency approved by the division rule in collaboration with the
             1054      board.
             1055          Section 16. Section 58-17b-305 is enacted to read:
             1056          58-17b-305. Qualifications for licensure of pharmacy technician.
             1057          (1) Each applicant for licensure as a pharmacy technician shall:
             1058          (a) submit an application in a form prescribed by the division;
             1059          (b) pay a fee determined by the department under Section 63-38-3.2 ;
             1060          (c) produce satisfactory evidence of good moral character as it relates to the applicant's
             1061      ability to practice pharmacy;
             1062          (d) complete a criminal background check and be free from criminal convictions as
             1063      required by Section 58-17b-307 , or as otherwise permitted by Section 58-1-501 ;
             1064          (e) have no physical or mental condition of a nature which prevents the applicant from
             1065      engaging in practice as a pharmacy technician with reasonable skill, competency, and safety to
             1066      the public;
             1067          (f) have completed a board approved program and curriculum of education and
             1068      training, meeting standards established by division rule made in collaboration with the board;
             1069      and
             1070          (g) successfully complete the examinations requirement within the time periods
             1071      established by division rule made in collaboration with the board.
             1072          (2) A pharmacist whose license has been denied, revoked, suspended, or restricted for
             1073      disciplinary purposes shall not be eligible to be a licensed pharmacy technician while on
             1074      probation with the division.
             1075          Section 17. Section 58-17b-306 is enacted to read:
             1076          58-17b-306. Qualifications for licensure as a pharmacy.
             1077          (1) Each applicant for licensure under this section, except for those applying for a class
             1078      D license, shall:
             1079          (a) submit a written application in the form prescribed by the division;
             1080          (b) pay a fee as determined by the department under Section 63-38-3.2 ;
             1081          (c) satisfy the division that the applicant, and each owner, officer, or manager of the



Text Box

- 36 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
             1082
     applicant have not engaged in any act, practice, or omission, which when considered with the
             1083      duties and responsibilities of a licensee under this section indicates there is cause to believe
             1084      that issuing a license to the applicant is inconsistent with the interest of the public's health,
             1085      safety, or welfare;
             1086          (d) demonstrate the licensee's operations will be in accordance with all federal, state,
             1087      and local laws relating to the type of activity engaged in by the licensee, including regulations
             1088      of the Federal Drug Enforcement Administration and Food and Drug Administration;
             1089          (e) maintain operating standards established by division rule made in collaboration
             1090      with the board; and
             1091          (f) acknowledge the division's authority to inspect the licensee's business premises
             1092      pursuant to Section 58-17b-103 .
             1093          (2) Each applicant applying for a class D license shall:
             1094          (a) submit a written application in the form prescribed by the division;
             1095          (b) pay a fee as determined by the department under Section 63-38-3.2 ;
             1096          (c) present to the division verification of licensure in the state where physically located
             1097      and verification that such license is in good standing;
             1098          (d) provide a statement of the scope of pharmacy services that will be provided and a
             1099      detailed description of the protocol as described by rule by which pharmacy care will be
             1100      provided, including any collaborative practice arrangements with other health care
             1101      practitioners;
             1102          (e) sign an affidavit attesting that any healthcare practitioners employed by the
             1103      applicant and physically located in Utah have the appropriate license issued by the division and
             1104      in good standing; and
             1105          (f) sign an affidavit attesting that the applicant will abide by the pharmacy laws and
             1106      regulations of the jurisdiction in which the S [ patient ] PHARMACY s is located.
             1107          (3) Each license issued under this section shall be issued for a single, specific address,
             1108      and is not transferable or assignable.
             1109          Section 18. Section 58-17b-307 is enacted to read:
             1110          58-17b-307. Qualification for licensure -- Criminal background checks.
             1111          (1) An applicant for licensure under this chapter shall submit fingerprint cards in a
             1112      form acceptable to the division at the time the license application is filed and shall consent to a



Text Box

- 37 -
             1113
     fingerprint background check by the Utah Bureau of Criminal Identification and the Federal
             1114      Bureau of Investigation regarding the application.
             1115          (2) The division shall request the Department of Public Safety to complete a Federal
             1116      Bureau of Investigation criminal background check for each applicant through the national
             1117      criminal history system (NCIC) or any successor system.
             1118          (3) If convicted of one or more felonies, an applicant must receive an absolute
             1119      discharge from the sentences for all felony convictions five or more years prior to the date of
             1120      filing an application for licensure under this chapter.
             1121          (4) For purposes of conducting the criminal background check required in Subsection
             1122      (1), the division shall have direct access to criminal background information maintained
             1123      pursuant to Title 53, Chapter 10, Part 2, Bureau of Criminal Identification.
             1124          (5) Any new pharmacist, pharmacy intern, or pharmacy technician license issued under
             1125      this section shall be conditional, pending completion of the criminal background check.
             1126      Notwithstanding Title 63, Chapter 46b, Administrative Procedures Act, if the criminal
             1127      background check discloses the applicant has failed to accurately disclose a criminal history,
             1128      the license shall be immediately and automatically revoked upon notice to the licensee.
             1129          (6) Any person whose conditional license has been revoked under Subsection (5) shall
             1130      be entitled to a postrevocation hearing to challenge the revocation. The hearing shall be
             1131      conducted in accordance with Title 63, Chapter 46b, Administrative Procedures Act.
             1132          Section 19. Section 58-17b-308 is enacted to read:
             1133          58-17b-308. Term of license -- Expiration -- Renewal.
             1134          (1) Except as provided in Subsection (2), each license issued under this chapter shall be
             1135      issued in accordance with a two-year renewal cycle established by rule. A renewal period may
             1136      be extended or shortened by as much as one year to maintain established renewal cycles or to
             1137      change an established renewal cycle. Each license automatically expires on the expiration date
             1138      shown on the license unless renewed by the licensee in accordance with Section 58-1-308 .
             1139          (2) The duration of a pharmacy intern license may be no longer than:
             1140          (a) one year for a license issued under Subsection 58-17b-304 (7)(b) or (c); or
             1141          (b) four years for a license issued under Subsection 58-17b-304 (7)(a).
             1142          (3) A pharmacy intern license issued under this chapter may not be renewed, but may
             1143      be extended by the division in collaboration with the board.



Text Box

- 38 -
             1144
         Section 20. Section 58-17b-309 is enacted to read:
             1145          58-17b-309. Exemptions from licensure.
             1146          (1) In addition to the exemptions from licensure in Section 58-1-307 , the following
             1147      individuals may engage in the acts or practices described in this Subsection (1) without being
             1148      licensed under this chapter:
             1149          (a) a person selling contact lenses in accordance with Section 58-16a-801 ; and
             1150          (b) an individual engaging in the practice of pharmacy technician under the direct
             1151      personal supervision of a pharmacist while making satisfactory progress in an approved
             1152      program as defined in division rule.
             1153          (2) In accordance with Subsection 58-1-303 (1)(a), an individual exempt under
             1154      Subsection (1)(b) must take all examinations as required by division rule following completion
             1155      of an approved curriculum of education, within the required time frame. This exemption
             1156      expires immediately upon notification of a failing score of an examination, and the individual
             1157      may not continue working as a pharmacy technician even under direct supervision.
             1158          Section 21. Section 58-17b-310 is enacted to read:
             1159          58-17b-310. Continuing education.
             1160          The division in collaboration with the board may establish by rule continuing education
             1161      requirements for each classification of licensure under this chapter.
             1162          Section 22. Section 58-17b-401 is enacted to read:
             1163     
Part 4. License Denial and Discipline

             1164          58-17b-401. Grounds for denial of licensure -- Disciplinary proceedings.
             1165          Grounds for the following action regarding a license issued under this chapter shall be
             1166      in accordance with Section 58-1-401 :
             1167          (1) refusal to issue a license to an applicant;
             1168          (2) refusal to renew the license of a licensee;
             1169          (3) to revoke, suspend, restrict, or place on probation the license of a licensee;
             1170          (4) to issue a public or private reprimand to a licensee;
             1171          (5) to issue cease and desist orders; and
             1172          (6) to issue an administrative fine or citation.
             1173          Section 23. Section 58-17b-501 is enacted to read:
             1174     
Part 5. Unlawful and Unprofessional Conduct



Text Box

- 39 -
             1175
         58-17b-501. Unlawful conduct.
             1176          "Unlawful conduct" includes:
             1177          (1) knowingly preventing or refusing to permit any authorized agent of the division to
             1178      conduct an inspection pursuant to Section 58-17b-103 ;
             1179          (2) failing to deliver the license, permit, or certificate to the division upon demand, if it
             1180      has been revoked, suspended, or refused;
             1181          (3) (a) using the title "pharmacist," "druggist," "pharmacy intern," "pharmacy
             1182      technician," or any term having similar meaning, except by a person licensed as a pharmacist,
             1183      pharmacy intern, or pharmacy technician; or
             1184          (b) conducting or transacting business under a name which contains, as part of that
             1185      name, the words "drugstore", "pharmacy", "drugs", "medicine store", "medicines", "drug shop",
             1186      "apothecary", "prescriptions", or any other term having a similar meaning, or in any manner
             1187      advertising, otherwise describing, or referring to the place of the conducted business or
             1188      profession, unless the place is a pharmacy issued a license by the division, except any
             1189      establishment selling nonprescription drugs and supplies may display signs bearing the words
             1190      "packaged drugs", "drug sundries", or "nonprescription drugs", and is not considered to be a
             1191      pharmacy or drugstore by reason of the display;
             1192          (4) buying, selling, causing to be sold, or offering for sale, any drug or device which
             1193      bears, or the package bears or originally did bear, the inscription "sample", "not for resale", "for
             1194      investigational or experimental use only", or other similar words, except when a cost is
             1195      incurred in the bona fide acquisition of an investigational or experimental drug;
             1196          (5) using to his own advantages or revealing to anyone other than the division, board,
             1197      and its authorized representatives, or to the courts, when relevant to any judicial or
             1198      administrative proceeding under this chapter, any information acquired under authority of this
             1199      chapter or concerning any method of process which is a trade secret;
             1200          (6) procuring or attempting to procure any drug for himself or to have someone else
             1201      procure or attempt to procure any drug:
             1202          (a) by fraud, deceit, misrepresentation, or subterfuge;
             1203          (b) by forgery or alteration of a prescription or any written order;
             1204          (c) by concealment of a material fact;
             1205          (d) by use of a false statement in any prescription, chart, order, or report; or



Text Box

- 40 -
             1206
         (e) by theft;
             1207          (7) filling, refilling, or advertising the filling or refilling of prescriptions for any
             1208      consumer or patient residing in this state if the person is not licensed:
             1209          (a) under this chapter; or
             1210          (b) in the state from which he is dispensing;
             1211          (8) requiring any employed pharmacist, pharmacy intern, pharmacy technician, or
             1212      authorized supportive personnel to engage in any conduct in violation of this chapter;
             1213          (9) being in possession of a prescription drug for any unlawful purpose;
             1214          (10) dispensing a prescription drug to anyone who does not have a prescription from a
             1215      practitioner or to anyone who he knows or should know is attempting to obtain drugs by fraud
             1216      or misrepresentation;
             1217          (11) selling, dispensing, or otherwise trafficking in prescription drugs when not
             1218      licensed to do so or when not exempted from licensure; and
             1219          (12) using a prescription drug or controlled substance for himself that was not lawfully
             1220      prescribed for him by a practitioner.
             1221          Section 24. Section 58-17b-502 is enacted to read:
             1222          58-17b-502. Unprofessional conduct.
             1223          "Unprofessional conduct" includes:
             1224          (1) willfully deceiving or attempting to deceive the division, the board, or their agents
             1225      as to any relevant matter regarding compliance under this chapter;
             1226          (2) (a) paying rebates to practitioners or any other health care providers, or entering
             1227      into any agreement with a medical practitioner or any other person for the payment or
             1228      acceptance of compensation or its economic equivalent for recommending the professional
             1229      services of either party, except as allowed under Subsection (2)(b); and
             1230          (b) price discounts conditional upon volume purchases are not prohibited under
             1231      Subsection (2)(a);
             1232          (3) misbranding or adulteration of any drug or device or the sale, distribution, or
             1233      dispensing of any outdated, misbranded, or adulterated drug or device;
             1234          (4) engaging in the sale or purchase of drugs or devices that are samples or packages
             1235      bearing the inscription "sample" or "not for resale" or similar words or phrases;
             1236          (5) accepting back and redistributing of any unused drug, or a part of it, after it has left



Text Box

- 41 -
             1237
     the premises of any pharmacy, unless the drug is in the original sealed unit dose package or
             1238      manufacturer's sealed container as defined in rule, except as provided in Section 58-17b-503 ;
             1239          (6) being employed as a pharmacist, pharmacy intern, or pharmacy technician, or
             1240      sharing or receiving compensation in any form arising out of an act incidental to professional
             1241      activities in the course of which any person requires him to engage in any aspect of the practice
             1242      of pharmacy in violation of this chapter;
             1243          (7) violating Federal Title II, P.L. 91, Controlled Substances Act, or Title 58, Chapter
             1244      37, Utah Controlled Substances Act, or rules and regulations adopted under either act;
             1245          (8) requiring or permitting pharmacy interns or technicians to engage in activities
             1246      outside the scope of practice for their respective license classifications as defined in this
             1247      chapter and division rules made in collaboration with the board, or beyond an individual's
             1248      scope of training and ability;
             1249          (9) administering without appropriate training as defined by rule:
             1250          (a) written guidelines or protocols of a practitioner or in conflict with such guidelines
             1251      or protocols; or
             1252          (b) a lawful order, when one is required by law;
             1253          (10) disclosing confidential patient information in violation of the provisions of the
             1254      Health Insurance Portability and Accountability Act of 1996 or other applicable law;
             1255          (11) engaging in the practice of pharmacy without a licensed pharmacist designated as
             1256      the pharmacist-in-charge;
             1257          (12) failing to report to the division any adverse action taken by another licensing
             1258      jurisdiction, government agency, law enforcement agency, or court for conduct that would
             1259      constitute grounds for action as defined in this section;
             1260          (13) preparing as a pharmacist or pharmacy intern, a prescription drug for sale to
             1261      another pharmacist or pharmaceutical facility; and
             1262          (14) preparing as a pharmacist or pharmacy intern, a prescription drug in a dosage form
             1263      which is regularly and commonly available from a manufacturer in quantities and strengths
             1264      prescribed by a practitioner.
             1265          Section 25. Section 58-17b-503 is enacted to read:
             1266          58-17b-503. Exception to unprofessional conduct.
             1267          (1) For purposes of this section:



Text Box

- 42 -
             1268
         (a) "ICFMR" means an intermediate care facility for the mentally retarded licensed as a
             1269      nursing care facility or a small health care facility under Title 26, Chapter 21, Health Care
             1270      Facility Licensing and Inspection Act.
             1271          (b) "Nursing care facility" has the same definition as in Section 26-21-2 .
             1272          (c) "Unit pack" means a single dose-single drug package which identification indicates
             1273      the lot number and expiration date for the drug.
             1274          (2) Notwithstanding the provisions of Subsection 58-17b-502 (5), a pharmacist may
             1275      accept back and redistribute any unused drug, or a part of it, after it has left the premises of the
             1276      pharmacy if:
             1277          (a) the drug was prescribed to a patient in a nursing care facility, a ICFMR, or state
             1278      prison facility, county jail, or state hospital;
             1279          (b) the drug was stored under the supervision of a licensed health care provider
             1280      according to manufacturer recommendations;
             1281          (c) the drug is in a unit pack or in the manufacturer's sealed container;
             1282          (d) the drug was returned to the original dispensing pharmacy;
             1283          (e) the drug was initially dispensed by a licensed pharmacist or licensed pharmacy
             1284      intern; and
             1285          (f) accepting back and redistribution of the drug complies with Federal Food and Drug
             1286      Administration and Drug Enforcement Administration regulations.
             1287          Section 26. Section 58-17b-504 is enacted to read:
             1288          58-17b-504. Penalty for unlawful or unprofessional conduct -- Fines -- Citations.
             1289          (1) Any person who violates the unlawful conduct provision defined in Subsection
             1290      58-1-501 (1)(a)(i) and Subsections 58-17b-501 (7) and (11) is guilty of a third degree felony.
             1291          (2) Any person who violates the unlawful conduct provisions defined in Subsection
             1292      58-1-501 (1)(a)(ii), Subsections 58-1-501 (1)(b) through (e) and Section 58-17b-501 , except
             1293      Subsections 58-17b-501 (7) and (11), is guilty of a class A misdemeanor.
             1294          (3) (a) Subject to Subsection (5), the division may assess administrative penalties in
             1295      accordance with the provisions of Section 58-17b-401 for acts of unprofessional or unlawful
             1296      conduct or any other appropriate administrative action in accordance with the provisions of
             1297      Section 58-17b-401 .
             1298          (b) An administrative penalty imposed pursuant to this section shall be deposited in the



Text Box

- 43 -
             1299
     General Fund as a dedicated credit to be used by the division for pharmacy licensee education
             1300      and enforcement as provided in Section 58-12b-505 .
             1301          (4) If a licensee has been convicted of violating Section 58-17b-501 prior to an
             1302      administrative finding of a violation of the same section, the licensee may not be assessed an
             1303      administrative fine under this chapter for the same offense for which the conviction was
             1304      obtained.
             1305          (5) (a) If upon inspection or investigation, the division concludes that a person has
             1306      violated the provisions of Section 58-17b-501 , 58-17b-502 , or Chapter 37, Utah Controlled
             1307      Substances Act, or any rule or order issued with respect to these provisions, and that
             1308      disciplinary action is appropriate, the director or the director's designee from within the
             1309      division shall promptly issue a citation to the person according to this chapter and any pertinent
             1310      rules, attempt to negotiate a stipulated settlement, or notify the person to appear before an
             1311      adjudicative proceeding conducted under Title 63, Chapter 46b, Administrative Procedures
             1312      Act.
             1313          (b) Any person who is in violation of the provisions of Section 58-17b-501 ,
             1314      58-17b-502 , or Chapter 37, Utah Controlled Substances Act, or any rule or order issued with
             1315      respect to these provisions, as evidenced by an uncontested citation, a stipulated settlement, or
             1316      by a finding of violation in an adjudicative proceeding, may be assessed a fine pursuant to this
             1317      Subsection (5) of up to $10,000 per single violation or up to $2,000 per day of ongoing
             1318      violation, whichever is greater, in accordance with a fine schedule established by rule, and
             1319      may, in addition to or in lieu of, be ordered to cease and desist from violating the provisions of
             1320      Section 58-17b-501 , 58-17b-502 , or Chapter 37, Utah Controlled Substances Act, or any rule
             1321      or order issued with respect to these provisions.
             1322          (c) Except for an administrative fine and a cease and desist order, the licensure
             1323      sanctions cited in Section 58-17b-401 may not be assessed through a citation.
             1324          (d) Each citation shall be in writing and specifically describe with particularity the
             1325      nature of the violation, including a reference to the provision of the chapter, rule, or order
             1326      alleged to have been violated. The citation shall clearly state that the recipient must notify the
             1327      division in writing within 20 calendar days of service of the citation if the recipient wishes to
             1328      contest the citation at a hearing conducted under Title 63, Chapter 46b, Administrative
             1329      Procedures Act. The citation shall clearly explain the consequences of failure to timely contest



Text Box

- 44 -
             1330
     the citation or to make payment of any fines assessed by the citation within the time specified
             1331      in the citation.
             1332          (e) Each citation issued under this section, or a copy of each citation, may be served
             1333      upon any person whom a summons may be served:
             1334          (i) in accordance with the Utah Rules of Civil Procedure;
             1335          (ii) personally or upon the person's agent by a division investigator or by any person
             1336      specially designated by the director; or
             1337          (iii) by mail.
             1338          (f) If within 20 calendar days from the service of a citation, the person to whom the
             1339      citation was issued fails to request a hearing to contest the citation, the citation becomes the
             1340      final order of the division and is not subject to further agency review. The period to contest the
             1341      citation may be extended by the division for cause.
             1342          (g) The division may refuse to issue or renew, suspend, revoke, or place on probation
             1343      the license of a licensee who fails to comply with the citation after it becomes final.
             1344          (h) The failure of an applicant for licensure to comply with a citation after it becomes
             1345      final is a ground of denial of license.
             1346          (i) No citation may be issued under this section after the expiration of six months
             1347      following the occurrence of any violation.
             1348          Section 27. Section 58-17b-505 is enacted to read:
             1349          58-17b-505. Educational and enforcement fund.
             1350          (1) The director may use the money collected pursuant to Section 58-17b-504 for the
             1351      following purposes:
             1352          (a) education and training of licensees under this chapter;
             1353          (b) enforcement of this chapter by:
             1354          (i) investigating unprofessional or unlawful conduct;
             1355          (ii) providing legal representation to the division when legal action is taken against a
             1356      person engaging in unprofessional or unlawful conduct;
             1357          (iii) monitoring compliance of renewal requirement; and
             1358          (iv) education and training of division staff and board members.
             1359          (2) All funding for the purposes listed in Subsection (1) is nonlapsing.
             1360          (3) Any penalty which is not paid may be collected by the director by either referring



Text Box

- 45 -
             1361
     the matter to a collection agency or bringing an action in the district court of the county in
             1362      which the person against whom the penalty is imposed resides or in the county where the office
             1363      of the director is located.
             1364          (4) Any county attorney or the attorney general of the state is to provide legal
             1365      assistance and advice to the director in any action to collect the penalty. In any action brought
             1366      to enforce the provisions of this section, reasonable attorney's fees and costs shall be awarded
             1367      in which the person against whom the penalty is imposed resides or in the county where the
             1368      office of the director is located.
             1369          Section 28. Section 58-17b-506 is enacted to read:
             1370          58-17b-506. Petitioning for reinstatement of licensure.
             1371          Any person whose license to practice pharmacy in this state has been revoked,
             1372      suspended, or surrendered voluntarily or by action of the division, shall have the right at
             1373      reasonable intervals, to petition the division for reinstatement of such license. Such petition
             1374      shall be made in writing and in the form prescribed by the division. Upon investigation and
             1375      hearing, the division may, in its discretion, grant or deny such petition, or it may modify its
             1376      original finding to reflect any circumstances that have changed sufficiently to warrant such
             1377      modifications. The division, also at its discretion, may require such person to pass an
             1378      examination or examinations for reentry into the practice of pharmacy.
             1379          Section 29. Section 58-17b-601 is enacted to read:
             1380     
Part 6. Regulation of the Practice of Pharmacy Operating Standards

             1381          58-17b-601. General operating standards.
             1382          (1) (a) The division shall make rules relating to the operations and conduct of facilities,
             1383      individuals, and entities which are regulated under this chapter, to protect the public health,
             1384      safety, and welfare.
             1385          (b) The rules shall be consistent with the regulations of the Federal Food and Drug
             1386      Administration and Drug Enforcement Administration, this chapter, and all other laws relating
             1387      to activities and persons regulated under this chapter.
             1388          (2) (a) This chapter does not prevent, restrict, or in any other manner interfere with the
             1389      sale of nonprescription drugs.
             1390          (b) The division may not make any rules under this chapter that require nonprescription
             1391      drugs to be sold by a licensed pharmacist or only in a pharmaceutical facility.



Text Box

- 46 -
             1392
         (c) The sale or distribution of nonprescription drugs does not constitute the practice of
             1393      pharmacy.
             1394          Section 30. Section 58-17b-602 is enacted to read:
             1395          58-17b-602. Prescription orders -- Information required -- Alteration -- Labels --
             1396      Signatures.
             1397          (1) The minimum information that shall be included in a prescription order and may be
             1398      defined by rule is:
             1399          (a) the prescriber's name, address, and telephone number, and, if the order is for a
             1400      controlled substance, the patient's age and the prescriber's DEA number;
             1401          (b) the patient's name and address or, in the case of an animal, name of the owner and
             1402      species of the animal;
             1403          (c) the date of issuance;
             1404          (d) the name of the medication or device prescribed and dispensing instructions, if
             1405      necessary;
             1406          (e) the directions for the use of the prescription, if appropriate, for the patient or
             1407      animal, any refill, special labeling, and other instructions;
             1408          (f) the prescriber's signature if the prescription order is written;
             1409          (g) if an electronically transmitted prescription order, prescribing practitioner's
             1410      electronic signature; and
             1411          (h) if a hard copy prescription order generated from electronic media, prescribing
             1412      practitioner's electronic or manual signature.
             1413          (2) The requirement of Subsection (1)(a) does not apply to prescription orders
             1414      dispensed for inpatients by hospital pharmacies if the prescriber is a current member of the
             1415      hospital staff and the prescription order is on file in the patient's medical record.
             1416          (3) The prescription order, except for controlled substance II, may be dispensed by
             1417      pharmacists or pharmacy interns upon an oral prescription of a practitioner, if the oral
             1418      prescription is promptly reduced to writing.
             1419          (4) (a) A pharmacist or pharmacy intern may not dispense or compound any
             1420      prescription of a practitioner if it shows evidence of alteration, erasure, or addition by any
             1421      person other than the person writing the prescription, except under Subsection (4)(b).
             1422          (b) A pharmacist or pharmacy intern dispensing or compounding the prescription may



Text Box

- 47 -
             1423
     alter or make additions after receiving permission of the prescriber, or may make entries or
             1424      additions on the prescription required by law or necessitated in the compounding and
             1425      dispensing procedures.
             1426          (5) Each drug dispensed shall have a label securely affixed to the container indicating
             1427      the following minimum information:
             1428          (a) the name, address, and telephone number of the pharmacy;
             1429          (b) the serial number of the prescription as assigned by the dispensing pharmacy;
             1430          (c) the filling date of the prescription or its last dispensing date;
             1431          (d) the name of the patient, or in the case of an animal, name of the owner and species
             1432      of the animal;
             1433          (e) the name of the prescriber;
             1434          (f) the directions for use and cautionary statements, if any, which are contained in the
             1435      prescription order or are needed;
             1436          (g) the trade, generic, or chemical name, amount dispensed and strength of dosage
             1437      form, but if multiple ingredient products with established proprietary or nonproprietary names
             1438      are prescribed, those products' names may be used; and
             1439          (h) the beyond use date.
             1440          (6) If the prescriber specifically indicates the name of the prescription product should
             1441      not appear on the label, then the trade, generic, or chemical name and strength of dosage form
             1442      may not be included.
             1443          Section 31. Section 58-17b-603 is enacted to read:
             1444          58-17b-603. Identification of pharmacy personnel.
             1445          (1) All individuals employed in a pharmacy facility having any contact with the public
             1446      or patients receiving services from that pharmacy facility shall wear on their person a clearly
             1447      visible and readable identification showing the individual's name and position.
             1448          (2) When communicating by any means, written, verbal, or electronic, pharmacy
             1449      personnel must identify themselves as to licensure classification.
             1450          Section 32. Section 58-17b-604 is enacted to read:
             1451          58-17b-604. Medication profiles.
             1452          (1) Each pharmacy shall establish a medication profile system for pharmacy patients
             1453      according to the standards established by division rules made in collaboration with the board.



Text Box

- 48 -
             1454
     The rules shall indicate the method for recording all prescription information.
             1455          (2) The pharmacy shall maintain the medication profile for any pharmacy patient who
             1456      expresses a desire for that professional service.
             1457          (3) The pharmacy may charge an appropriate professional fee for this service and for
             1458      copying or providing information in the medication profile to another authorized person.
             1459          (4) A pharmacist, pharmacy intern, or pharmacy technician may not release or discuss
             1460      the information contained in a prescription or patient's medication profile to anyone except:
             1461          (a) the pharmacy patient in person or the pharmacy patient's legal guardian or designee;
             1462          (b) a lawfully authorized federal, state, or local drug enforcement officer;
             1463          (c) a third party payment program administered under terms authorized by the
             1464      pharmacy patient;
             1465          (d) a pharmacist, pharmacy intern, or pharmacy technician providing pharmacy
             1466      services to the patient or a prescribing practitioner providing professional services to the
             1467      patient;
             1468          (e) another pharmacist, pharmacy intern, pharmacy technician, or prescribing
             1469      practitioner to whom the patient has requested a prescription transfer; or
             1470          (f) the pharmacy patient's attorney, after the presentation of a written authorization
             1471      signed by the:
             1472          (i) patient, before a notary public;
             1473          (ii) parent or lawful guardian, if the patient is a minor;
             1474          (iii) lawful guardian, if the patient is incompetent; or
             1475          (iv) personal representative, if the patient is deceased.
             1476          Section 33. Section 58-17b-605 is enacted to read:
             1477          58-17b-605. Drug product equivalents.
             1478          (1) A pharmacist or pharmacy intern dispensing a prescription order for a specific drug
             1479      by brand or proprietary name may substitute another drug product equivalent if:
             1480          (a) the purchaser specifically requests or consents to the substitution of a drug product
             1481      equivalent;
             1482          (b) the substituted drug product equivalent is of the same generic type and is
             1483      designated the therapeutic equivalent in the approved drug products with therapeutic
             1484      equivalence evaluations prepared by the Center for Drug Evaluation and Research of the



Text Box

- 49 -
             1485
     Federal Food and Drug Administration;
             1486          (c) the substituted drug product is permitted to move in interstate commerce;
             1487          (d) the pharmacist or pharmacy intern counsels the patient on the use and the expected
             1488      response to the prescribed drug, whether a substitute or not, and the substitution is not
             1489      otherwise prohibited by this chapter;
             1490          (e) the prescribing practitioner has not indicated that an equivalent drug product is not
             1491      to be substituted as provided in Subsection (5); and
             1492          (f) the substitution is not otherwise prohibited by law.
             1493          (2) (a) Each out-of-state mail service pharmacy dispensing a substituted drug product
             1494      into this state shall notify the patient of substitution either by telephone or in writing.
             1495          (b) Each out-of-state mail service pharmacy shall comply with the requirements of this
             1496      chapter with respect to drugs which may be substituted, including labeling and record keeping,
             1497      when dispensing substituted drug products.
             1498          (3) Pharmacists or pharmacy interns may not substitute without the prescriber's
             1499      authorization on trade name drug product prescriptions unless the product is currently
             1500      categorized in the approved drug products with therapeutic equivalence evaluations prepared
             1501      by the Center for Drug Evaluation and Research of the Federal Food and Drug Administration
             1502      as a drug product considered to be therapeutically equivalent to another drug product.
             1503          (4) A pharmacist or pharmacy intern who dispenses a prescription with a drug product
             1504      equivalent under this section assumes no greater liability than would be incurred had the
             1505      pharmacist or pharmacy intern dispensed the prescription with the drug product prescribed.
             1506          (5) (a) If, in the opinion of the practitioner, it is in the best interest of the patient that an
             1507      equivalent drug product not be substituted, the practitioner may indicate a prohibition on
             1508      substitution either by writing "dispense as written" or may sign in the appropriate space where
             1509      two lines have been preprinted on a prescription order and captioned "dispense as written" or
             1510      "substitution permitted".
             1511          (b) If the prescription is communicated orally by the practitioner to the pharmacist or
             1512      pharmacy intern, the practitioner shall indicate the prohibition on substitution and that
             1513      indication shall be noted in writing by the pharmacist or pharmacy intern with the name of the
             1514      practitioner and the words "orally by" and the initials of the pharmacy practitioner written after
             1515      it.



Text Box

- 50 -
             1516
         (6) The substitution, if any, shall be communicated to the purchaser. The container
             1517      shall be labeled with the name of the drug dispensed and the pharmacist, pharmacy intern, or
             1518      pharmacy technician shall indicate on the file copy of the prescription both the name of the
             1519      prescribed drug and the name of the drug dispensed in its place.
             1520          (7) Failure of a licensed medical practitioner to specify that no substitution is
             1521      authorized does not constitute evidence of negligence.
             1522          Section 34. Section 58-17b-606 is enacted to read:
             1523          58-17b-606. Restrictive drug formulary prohibited.
             1524          (1) As used in this section:
             1525          (a) "Generic form" means a prescription drug that is available in generic form and has
             1526      an A rating in the United States Pharmacopeia and Drug Index.
             1527          (b) "Legend drug" means any drug that requires a prescription under state or federal
             1528      law.
             1529          (c) "Restrictive drug formulary" means a list of legend drugs, other than drugs for
             1530      cosmetic purposes, that are prohibited by the Department of Health from dispensation, but are
             1531      approved by the Federal Food and Drug Administration.
             1532          (2) A practitioner may prescribe legend drugs in accordance with this chapter that, in
             1533      his professional judgment and within the lawful scope of his practice, he considers appropriate
             1534      for the diagnosis and treatment of his patient.
             1535          (3) Except as provided in Subsection (4), the Department of Health may not maintain a
             1536      restrictive drug formulary that restricts a physician's ability to treat a patient with a legend drug
             1537      that has been approved and designated as safe and effective by the Federal Food and Drug
             1538      Administration, except for drugs for cosmetic purposes.
             1539          (4) When a multisource legend drug is available in the generic form, the Department of
             1540      Health may only reimburse for the generic form of the drug unless the treating physician
             1541      demonstrates to the Department of Health a medical necessity for dispensing the nongeneric,
             1542      brand-name legend drug.
             1543          (5) This section does not affect the state's ability to exercise the exclusion options
             1544      available under the Federal Omnibus Budget Reconciliation Act of 1990.
             1545          Section 35. Section 58-17b-607 is enacted to read:
             1546          58-17b-607. Drug substitution is not the practice of medicine -- Other causes of



Text Box

- 51 -
             1547
     action not denied.
             1548          (1) The substitution of any drug by a licensed pharmacist or pharmacy intern under this
             1549      chapter does not constitute the practice of medicine.
             1550          (2) This chapter may not be construed to deny any individual a cause of action against
             1551      a pharmacist, pharmacy intern, or his employer for violations of this chapter, including failure
             1552      to observe accepted standards of care of the pharmaceutical profession.
             1553          Section 36. Section 58-17b-608 is enacted to read:
             1554          58-17b-608. Emergency refills.
             1555          (1) In the interest of the patient's health, a pharmacist or pharmacy intern may, in an
             1556      emergency, refill a prescription for a patient, but only if the prescribing practitioner is not
             1557      available promptly to authorize the refill and only if in the professional judgment of the
             1558      pharmacist or pharmacy intern the prescription should be refilled.
             1559          (2) Only sufficient medication as necessary in the emergency may be furnished by the
             1560      pharmacist or pharmacy intern, not to exceed a three-day supply.
             1561          (3) The practitioner shall be contacted as soon as possible for further instructions
             1562      concerning the emergency.
             1563          Section 37. Section 58-17b-609 is enacted to read:
             1564          58-17b-609. Limitation on prescriptions and refills -- Controlled Substances Act
             1565      not affected -- Legend drugs.
             1566          (1) A prescription for any prescription drug may not be dispensed after one year from
             1567      the date it was initiated except as otherwise provided in Chapter 37, Utah Controlled
             1568      Substances Act.
             1569          (2) A prescription authorized to be refilled may not be refilled after one year from the
             1570      original issue date.
             1571          (3) A practitioner may not be prohibited from issuing a new prescription for the same
             1572      drug orally, in writing, or by electronic transmission.
             1573          (4) Nothing in this chapter affects Chapter 37, Utah Controlled Substances Act.
             1574          (5) Prescriptions for a legend drug written by a licensed prescribing practitioner in
             1575      another state may be filled or refilled by a pharmacist or pharmacy intern in this state, and the
             1576      pharmacist or pharmacy intern knows the prescribing practitioner holds a current license.
             1577          Section 38. Section 58-17b-610 is enacted to read:



Text Box

- 52 -
             1578
         58-17b-610. Patients' immediate needs.
             1579          This chapter may not be construed to prevent the personal administration of drugs or
             1580      medicines by practitioners licensed to prescribe in order to supply the immediate needs of their
             1581      patients. Immediate need for a patient includes giving out drug samples for up to a three-day
             1582      supply or the amount necessary to determine the best pharmaceutical agent for that specific
             1583      patient.
             1584          Section 39. Section 58-17b-611 is enacted to read:
             1585          58-17b-611. Pharmacy records.
             1586          (1) Each pharmacy shall maintain its prescription files and other records in accordance
             1587      with this chapter, division rules made in collaboration with the board, and federal regulations.
             1588          (2) Each out-of-state mail service pharmacy shall maintain its prescription files in
             1589      accordance with applicable rules or regulations of the state in which its facilities are located
             1590      and federal regulations.
             1591          Section 40. Section 58-17b-612 is enacted to read:
             1592          58-17b-612. Supervision -- Pharmacist-in-charge.
             1593          (1) (a) Any pharmacy, except a wholesaler, distributor, or out-of-state mail service
             1594      pharmacy, shall be under the general supervision of at least one pharmacist licensed to practice
             1595      in Utah. One pharmacist licensed in Utah shall be designated as the pharmacist-in-charge,
             1596      whose responsibility it is to oversee the operation of the pharmacy.
             1597          (b) Notwithstanding the provisions of Subsection 58-17b-102 (63), a supervising
             1598      pharmacist does not have to be in the pharmacy or care facility but shall be available via a
             1599      telepharmacy system for immediate contact with the supervised pharmacy technician or
             1600      pharmacy intern if:
             1601          (i) the pharmacy is located in:
             1602          (A) a remote rural hospital, as defined in Section 26-21-13.6 ; or
             1603          (B) a clinic located in a remote rural county with less than 20 people per square mile;
             1604          (ii) the supervising pharmacist described in Subsection (1)(a), is not available; and
             1605          (iii) the telepharmacy system maintains records and files quarterly reports as required
             1606      by division rule to assure that patient safety is not compromised.
             1607          (2) Each out-of-state mail service pharmacy shall designate and identify to the division
             1608      a pharmacist holding a current license in good standing issued by the state in which the



Text Box

Senate 2nd Reading Amendments 2-20-2004 rd/cjd

- 53 -
Senate Committee Amendments 2-13-2004 rd/cjd
             1609
     pharmacy is located and who serves as the pharmacist-in-charge for all purposes under this
             1610      chapter.
             1611          Section 41. Section 58-17b-613 is enacted to read:
             1612          58-17b-613. Patient counseling.
             1613          (1) Every pharmacy facility shall orally offer to counsel a patient or a patient's agent in
             1614      a personal face-to-face discussion with respect to each prescription drug dispensed, if the
             1615      patient or patient's agent:
             1616          (a) delivers the prescription in person to the pharmacist or pharmacy intern; or
             1617          (b) receives the drug in person at the time it is dispensed at the pharmacy facility.
             1618          (2) A pharmacist or pharmacy intern shall provide counseling to each patient, and shall
             1619      provide the patient with a toll-free telephone number by which the patient may contact a
             1620      pharmacist at the dispensing pharmacy during normal business hours and receive oral
             1621      counseling, with respect to each prescription drug dispensed if the patient provides or the
             1622      prescription is otherwise provided to the pharmacy facility by a means other than personal
             1623      delivery, and the dispensed prescription drug is mailed or otherwise delivered to the patient
             1624      outside of the pharmacy facility.
             1624a      S (3)(a) THE PROVISIONS OF SUBSECTIONS (1)AND (2) DO NOT APPLY TO INCARCERATED
             1624b      PATIENTS OR PERSONS OTHERWISE UNDER THE JURISDICTION OF THE UTAH DEPARTMENT OF
             1624c      CORRECTIONS OR A COUNTY DETENTION FACILITY.
             1624d          (b)A WRITTEN COMMUNICATION WITH A PERSON DESCRIBED IN SUBSECTION (3)(a) SHALL
             1624e      BE USED BY A PHARMACIST OR PHARMACY INTERN IN LIEU OF A FACE TO FACE OR TELEPHONIC
             1624f      COMMUNICATION FOR THE PURPOSE OF COUNSELING THE PATIENT. s
             1625          Section 42. Section 58-17b-614 is enacted to read:
             1626          58-17b-614. Notification.
             1627          (1) A pharmacy shall report in writing to the division not later than ten business days
             1628      after the date of:
             1629          (a) a permanent closure of the pharmacy facility;
             1630          (b) a change of name or ownership;
             1631          (c) a change of location of the pharmacy facility;
             1632          (d) a sale or transfer of any controlled substance as a result of the permanent closing or
             1633      change of ownership of the pharmacy facility;
             1634          (e) any matter or occurrence that the board requires by rule to be reported;
             1635          (f) a final S ADMINISTRATIVE, DISCIPLINARY s order against the pharmacy license holder
             1635a      by the regulatory or licensing
             1636      agency of the state in which the pharmacy is located if the pharmacy is a class D pharmacy; or
             1637          (g) a final order against a pharmacist who is designated as the pharmacist-in-charge of
             1638      the pharmacy by the regulatory or licensing agency of the state in which the pharmacy is


             1639      located if the pharmacy is a class D pharmacy.



Text Box

- 54 -
             1640
         (2) A pharmacy shall report in writing to the division a disaster, accident, or emergency
             1641      that may effect purity, or labeling of a drug, medication, device, or other material used in the
             1642      diagnosis or treatment of injury, illness, or disease immediately on the occurrence of the
             1643      disaster, accident, or emergency as defined by rule. The reporting pharmacy shall maintain a
             1644      copy of any notification required by this section for two years and make a copy available for
             1645      inspection.
             1646          Section 43. Section 58-17b-615 is enacted to read:
             1647          58-17b-615. Sale of prescription drugs not in normal course of business.
             1648          (1) As used in this section, "seller" means a person selling prescription drugs or
             1649      devices owned or lawfully controlled by him, or a party arranging for the sale of prescription
             1650      drugs or devices owned by or lawfully controlled by another person, including salvage
             1651      companies that acquire prescription drugs and devices from, or act as an agent or representative
             1652      for freight haulers and forwarders.
             1653          (2) Any sale of prescription drugs in bankruptcy, at public auction, at freight
             1654      liquidation sales, or any other sale of prescription drugs other than in the normal course of
             1655      business or practice shall comply with the following:
             1656          (a) a seller of prescription drugs shall be licensed by the division as a prescription drug
             1657      distributor or wholesaler with a regular license, or a temporary license for that sale only, before
             1658      engaging in the sale of any prescription drugs; and
             1659          (b) a person licensed as a pharmacy under this chapter may not acquire by purchase or
             1660      other means prescription drugs or devices outside the normal course of business within the
             1661      meaning of this section unless:
             1662          (i) the prescription drugs or devices are accompanied by a certificate signed by a
             1663      licensed pharmacist employed or retained by the seller, as required in Subsection (3), attesting
             1664      that the prescription drugs or devices have not been adversely affected by circumstances
             1665      relating to their transportation, storage, or distribution; and
             1666          (ii) the licensee acquiring the prescription drugs or devices employs a qualified
             1667      pharmacist who is responsible for determining that all prescription drugs being acquired do not
             1668      pose any threat to the public welfare if introduced into commerce than would be presented by
             1669      the acquisition of those prescription drugs and devices in the normal course of business through
             1670      established channels of prescription drug distribution.



Text Box

- 55 -
             1671
         (3) A seller of prescription drugs outside the normal course of business shall retain the
             1672      services of a qualified pharmacist licensed to practice in the state to serve as either an employee
             1673      or independent consultant to determine if the:
             1674          (a) prescription drugs and devices to be offered for sale have been transported, stored,
             1675      and distributed in accordance with applicable federal, state, and local laws; and
             1676          (b) condition of the prescription drugs and devices to be offered for sale has been
             1677      adversely affected by the circumstances of transportation, storage, or distribution.
             1678          (4) The written notice provided to the division prior to the sale of any prescription
             1679      drugs or devices under this section shall contain written verification of the pharmacist retained
             1680      by the seller, stating the drugs or devices offered for sale have not been adversely affected by
             1681      the circumstances of transportation, storage, or distribution.
             1682          (5) A pharmacist employed by a seller under Subsection (3) or a pharmacy, distributor,
             1683      or wholesaler for whom that pharmacist may be employed or in which he may have an interest,
             1684      may not purchase any prescription drugs or devices from the seller for which that pharmacist
             1685      has provided verification regarding the drugs or devices.
             1686          Section 44. Section 58-17b-616 is enacted to read:
             1687          58-17b-616. Drug stock sales -- Labeling.
             1688          (1) A manufacturer, wholesaler, or distributor of prescription drugs may not sell or give
             1689      any prescription drug to any person unless the prescription drug stock container bears a label
             1690      containing information as defined by rule the name and place of business of the manufacturer
             1691      of the finished dosage form of the drug, and if different from the manufacturer, the name and
             1692      place of business of the packer or distributor.
             1693          (2) Each tablet or capsule shall be marked with an identification code or monogram,
             1694      unless waived by the division.
             1695          (3) Each stock package shall bear an expiration date and lot number.
             1696          Section 45. Section 58-17b-617 is enacted to read:
             1697          58-17b-617. Limitations on distribution of prescription drugs by pharmaceutical
             1698      manufacturers or wholesalers.
             1699          (1) A pharmaceutical manufacturer or pharmaceutical wholesaler may not provide a
             1700      prescription drug to any person, except as defined by rule.
             1701          (2) (a) Prescription drugs that are not controlled substances may be:



Text Box

House Floor Amendments 2-27-2004 ch/cjd

Senate 3rd Reading Amendments 2-24-2004 rd/cjd

- 56 -
Senate 2nd Reading Amendments 2-20-2004 rd/cjd
             1702
         (i) distributed or provided as drug samples to a person licensed within the state to sell,
             1703      prescribe, administer, or conduct research with legend drugs; and
             1704          (ii) supplied in connection with a manufacturer's patient assistance program to be
             1705      distributed to qualifying patients enrolled in the program.
             1706          (b) Controlled substance prescription drugs may be sold or provided only:
             1707          (i) upon the issuance of an order or request by a person appropriately licensed under
             1708      state and federal law to sell, prescribe, administer, or conduct research with prescription drugs;
             1709      and
             1710          (ii) upon the establishment of documents in the possession of the manufacturer or
             1711      distributor recording the purchaser, type of drug, quantity of drug, date of shipment, and date of
             1712      delivery.
             1713          (3) Purchasers or those in receipt of drugs under this section shall maintain records in
             1714      accordance with federal and state laws regarding controlled substances.
             1715          Section 46. Section 58-17b-618 is enacted to read:
             1716          58-17b-618. Compliance with federal laws.
             1717          The entities licensed under Sections 58-17b-301 and 58-17b-302 shall comply with all
             1718      state and federal laws and regulations relating to the practice of pharmacy.
             1719          Section 47. Section 58-17b-619 is enacted to read:
             1720          58-17b-619. Third party payors -- Health maintenance organizations.
             1721          (1) Any third party payor for pharmaceutical services within the state S , OR ITS AGENT OR
             1721a      CONTRACTOR s may not require
             1722      any pharmacy patient to obtain prescription S [ drugs ] DRUG - BENEFITS s from a specific
             1722a      out-of-state H [ or a Utah ] h
             1723      pharmacy as a condition of obtaining third party payment S PRESCRIPTION DRUG BENEFIT
             1723a      COVERAGE s as defined in rule.
             1724          (2) S (a) s This section does not prohibit any third party payor of pharmaceutical services,
             1724a      who
             1725      provides for reimbursement to the pharmacy patient or payment on his behalf, from exercising
             1726      the right to limit the amount reimbursed for the cost of prescription drugs based upon the cost
             1727      of identical prescription drugs available through a designated out-of-state pharmacy.
             1727a           S (b) NOTWITHSTANDING SUBSECTION (2)(a), ANY THIRD PARTY PAYOR OF
             1727b      PHARMACEUTICAL SERVICES MAY RESTRICT THE TYPE OF OUTLET WHERE A PATIENT MAY
             1727c      OBTAIN CERTAIN PRESCRIPTIVE DRUGS AND DEVICES, SUCH AS INJECTABLE MEDICATIONS,
             1727d      THAT ARE NOT READILY AVAILABLE IN ALL PHARMACIES. THE PAYOR MAY ALSO RESTRICT
             1727e      ACCESS TO NO MORE THAN ONE MAIL-ORDER PHARMACY. s
             1728          (3) Each third party payor of pharmaceutical services shall identify as a part of the third
             1729      party agreement or contract the designated out-of-state pharmacy which shall be used as the
             1730      base line comparison.
             1731          (4) (a) A violation of this section is a class A misdemeanor.
             1732          (b) Each violation of this section is a separate offense.




Text Box

- 57 -
             1733
         Section 48. Section 58-17b-620 is enacted to read:
             1734          58-17b-620. Prescriptions issued within the public health system.
             1735          (1) As used in this section:
             1736          (a) "Department of Health" means the state Department of Health created in Section
             1737      26-1-4 .
             1738          (b) "Health department" means either the Department of Health or a local health
             1739      department.
             1740          (c) "Local health departments" mean the local health departments created in Title 26A,
             1741      Chapter 1, Local Health Departments.
             1742          (2) A health department may implement the prescription procedure under Subsection
             1743      (3) for prescription drugs, other than controlled substances, for use in clinics providing:
             1744          (a) sexually transmitted disease treatment;
             1745          (b) fluoride treatment; or
             1746          (c) travel immunization.
             1747          (3) The following prescription procedure shall be carried out in accordance with the
             1748      requirements of Subsection (4) and may be used only in the clinics listed under Subsection (2):
             1749          (a) a physician writes and signs a prescription for prescription drugs, other than
             1750      controlled substances, without the name and address of the patient and without the date the
             1751      prescription is provided to the patient; and
             1752          (b) the physician authorizes a registered nurse employed by the health department to
             1753      complete the prescription written under this Subsection (3) by inserting the patient's name and
             1754      address, and the date the prescription is provided to the patient, in accordance with the
             1755      physician's standing written orders and a written health department protocol approved by the
             1756      physician and the medical director of the state Department of Health.
             1757          (4) When allowing prescriptions to be written under Subsection (3), the health
             1758      department shall employ a physician who:
             1759          (a) assumes specific responsibility for all prescriptions issued in his name under the
             1760      procedure in Subsection (3) by the health department; and
             1761          (b) enters into a written, signed agreement with the health department, which
             1762      agreement is approved by the division and state:
             1763          (i) the terms and conditions under which the physician will prepare and sign



Text Box

- 58 -
             1764
     prescriptions that do not include the name and address of the patient and the date the
             1765      prescription is provided to the patient;
             1766          (ii) the methods which will be used to ensure the signed prescriptions are secure and
             1767      not available for unauthorized use;
             1768          (iii) the minimum qualifications and training of a registered nurse authorized by the
             1769      physician and department to complete and provide prescriptions to a patient;
             1770          (iv) under what conditions prescriptions completed by an authorized registered nurse
             1771      will be provided to a patient in accordance with standing orders and written protocols, and the
             1772      specific prescription drugs for which prescriptions may be written;
             1773          (v) the manner in which the physician will audit and review the records of patients
             1774      receiving prescriptions; and
             1775          (vi) the manner in which records of prescriptions issued will be maintained for audit by
             1776      the physician and division.
             1777          (5) The health department shall file and maintain with the division a current copy of all
             1778      agreements signed by physicians under Subsection (4).
             1779          (6) (a) All prescription forms to be used by a physician and health department in
             1780      accordance with this section shall be serially numbered according to a numbering system
             1781      assigned to that health department.
             1782          (b) All prescriptions issued shall contain all information required under this chapter
             1783      and rules adopted under this chapter.
             1784          Section 49. Section 58-17b-621 is enacted to read:
             1785          58-17b-621. Automated pharmacy systems.
             1786          Automated pharmacy systems can be utilized in licensed pharmacies, remote locations
             1787      under the jurisdiction of the Utah State Board of Pharmacy, and licensed health care facilities
             1788      where legally permissible, as approved by the division in collaboration with the board, and
             1789      described in rule.
             1790          Section 50. Section 58-17b-701 is enacted to read:
             1791     
Part 7. Incapacity

             1792          58-17b-701. Mentally incompetent or incapacitated pharmacist -- Division action
             1793      and procedures.
             1794          (1) As used in this section:



Text Box

- 59 -
             1795
         (a) "Incapacitated person" has the same definition as in Section 75-1-201 .
             1796          (b) "Mentally ill" has the same definition as in Section 62A-15-602 .
             1797          (2) If a court of competent jurisdiction determines a pharmacist is an incapacitated
             1798      person, or that he is mentally ill and unable to safely engage in the practice of pharmacy, the
             1799      director shall immediately suspend the license of the pharmacist upon the entry of the judgment
             1800      of the court, without further proceedings under Title 63, Chapter 46b, Administrative
             1801      Procedures Act, regardless of whether an appeal from the court's ruling is pending. The
             1802      director shall promptly notify the pharmacist, in writing, of the suspension.
             1803          (3) (a) If the division and a majority of the board find reasonable cause to believe a
             1804      pharmacist, who is not determined judicially to be an incapacitated person or to be mentally ill,
             1805      is incapable of practicing pharmacy with reasonable skill regarding the safety of patients,
             1806      because of illness, excessive use of drugs or alcohol, or as a result of any mental or physical
             1807      condition, the board shall recommend that the director file a petition with the division, and
             1808      cause the petition to be served upon the pharmacist with a notice of hearing on the sole issue of
             1809      the capacity of the pharmacist to competently and safely engage in the practice of pharmacy.
             1810          (b) The hearing shall be conducted under Section 58-1-109 and Title 63, Chapter 46b,
             1811      Administrative Procedures Act, except as provided in Subsection (4).
             1812          (4) (a) Every pharmacist who accepts the privilege of being licensed under this chapter
             1813      gives consent to:
             1814          (i) submitting at his own expense to an immediate mental or physical examination
             1815      when directed in writing by the division, with the consent of a majority of the board, to do so;
             1816      and
             1817          (ii) the admissibility of the reports of the examining practitioner's testimony or
             1818      examination in any proceeding regarding the license of the pharmacist, and waives all
             1819      objections on the ground the reports constitute a privileged communication.
             1820          (b) The examination may be ordered by the division, with the consent of a majority of
             1821      the board, only upon a finding of reasonable cause to believe:
             1822          (i) the pharmacist is mentally ill or incapacitated or otherwise unable to practice
             1823      pharmacy with reasonable skill and safety; and
             1824          (ii) immediate action by the division and the board is necessary to prevent harm to the
             1825      pharmacist's patients or the general public.



Text Box

- 60 -
             1826
         (c) (i) Failure of a pharmacist to submit to the examination ordered under this section
             1827      is a ground for the division's immediate suspension of the pharmacist's license by written order
             1828      of the director.
             1829          (ii) The division may enter the order of suspension without further compliance with
             1830      Title 63, Chapter 46b, Administrative Procedures Act, unless the division finds the failure to
             1831      submit to the examination ordered under this section was due to circumstances beyond the
             1832      control of the pharmacist and was not related directly to the illness or incapacity of the
             1833      pharmacist.
             1834          (5) (a) A pharmacist whose license is suspended under Subsection (2) or (4) has the
             1835      right to a hearing to appeal the suspension within ten days after the license is suspended.
             1836          (b) The hearing held under this Subsection (5) shall be conducted in accordance with
             1837      Sections 58-1-108 and 58-1-109 for the sole purpose of determining if sufficient basis exists
             1838      for the continuance of the order of suspension in order to prevent harm to the pharmacist's
             1839      patients or the general public.
             1840          (6) A pharmacist whose license is revoked, suspended, or in any way restricted under
             1841      this section may request the division and the board to consider, at reasonable intervals,
             1842      evidence presented by the pharmacist, under procedures established by division rule, regarding
             1843      any change in the pharmacist's condition, to determine whether:
             1844          (a) he is or is not able to safely and competently engage in the practice of pharmacy;
             1845      and
             1846          (b) he is qualified to have his licensure to practice under this chapter restored
             1847      completely or in part.
             1848          Section 51. Section 58-24a-105 is amended to read:
             1849           58-24a-105. Administration of agents -- Limitation.
             1850          (1) Physical therapists may administer the following agents under the provisions of
             1851      Subsection (2):
             1852          (a) topically applied medicinal agents, including steroids and analgesics for wound care
             1853      and for musculoskeletal treatment using iontophoresis or phonorphoresis; and
             1854          (b) pharmaceutical aerosols for pulmonary hygiene in an institutional setting in which
             1855      the services of a licensed respiratory therapist are not available in the institution or within a
             1856      ten-mile radius of the institution.



Text Box

- 61 -
             1857
         (2) The topical application or aerosol administration by a physical therapist of a
             1858      prescription drug as defined in Section [ 58-17a-102 ] 58-17b-102 may be only upon the written
             1859      prescription of a practitioner licensed to prescribe that drug.
             1860          (3) This section does not authorize a physical therapist to possess for dispensing or
             1861      dispense a prescription drug.
             1862          Section 52. Section 58-37-6 is amended to read:
             1863           58-37-6. License to manufacture, produce, distribute, dispense, administer, or
             1864      conduct research -- Issuance by department -- Denial, suspension, or revocation --
             1865      Records required -- Prescriptions.
             1866          (1) (a) The department may adopt rules relating to the licensing and control of the
             1867      manufacture, distribution, production, prescription, administration, dispensing, conducting of
             1868      research with, and performing of laboratory analysis upon controlled substances within this
             1869      state.
             1870          (b) The department may assess reasonable fees to defray the cost of issuing original
             1871      and renewal licenses under this chapter pursuant to Section 63-38-3.2 .
             1872          (c) The director of the department may delegate to any division or agency within the
             1873      department, authority to perform the responsibilities and functions prescribed to the department
             1874      under this chapter if the delegated authority is consistent with the function of the division or
             1875      agency provided by law.
             1876          (2) (a) (i) Every person who manufactures, produces, distributes, prescribes, dispenses,
             1877      administers, conducts research with, or performs laboratory analysis upon any controlled
             1878      substance in Schedules II through V within this state, or who proposes to engage in
             1879      manufacturing, producing, distributing, prescribing, dispensing, administering, conducting
             1880      research with, or performing laboratory analysis upon controlled substances included in
             1881      Schedules II through V within this state shall obtain a license issued by the department.
             1882          (ii) The division shall issue each license under this chapter in accordance with a
             1883      two-year renewal cycle established by rule. The division may by rule extend or shorten a
             1884      renewal period by as much as one year to stagger the renewal cycles it administers.
             1885          (b) Persons licensed to manufacture, produce, distribute, prescribe, dispense,
             1886      administer, conduct research with, or perform laboratory analysis upon controlled substances in
             1887      Schedules II through V within this state may possess, manufacture, produce, distribute,



Text Box

- 62 -
             1888
     prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon
             1889      those substances to the extent authorized by their license and in conformity with this chapter.
             1890          (c) The following persons are not required to obtain a license and may lawfully possess
             1891      controlled substances under this section:
             1892          (i) an agent or employee, except a sales representative, of any registered manufacturer,
             1893      distributor, or dispenser of any controlled substance, if the agent or employee is acting in the
             1894      usual course of his business or employment; however, nothing in this Subsection (2) shall be
             1895      interpreted to permit an agent, employee, sales representative, or detail man to maintain an
             1896      inventory of controlled substances separate from the location of his employer's registered and
             1897      licensed place of business;
             1898          (ii) a motor carrier or warehouseman, or an employee of a motor carrier or
             1899      warehouseman, who possesses any controlled substance in the usual course of his business or
             1900      employment; and
             1901          (iii) an ultimate user, or any person who possesses any controlled substance pursuant to
             1902      a lawful order of a practitioner.
             1903          (d) The department may enact rules waiving the license requirement for certain
             1904      manufacturers, producers, distributors, prescribers, dispensers, administrators, research
             1905      practitioners, or laboratories performing analysis if consistent with the public health and safety.
             1906          (e) A separate license is required at each principal place of business or professional
             1907      practice where the applicant manufactures, produces, distributes, prescribes, dispenses,
             1908      administers, conducts research with, or performs laboratory analysis upon controlled
             1909      substances.
             1910          (f) The department may enact rules providing for the inspection of a licensee or
             1911      applicant's establishment, and may inspect the establishment according to those rules.
             1912          (3) (a) Upon proper application, the department shall license a qualified applicant to
             1913      manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon
             1914      controlled substances included in Schedules I through V, unless it determines that issuance of a
             1915      license is inconsistent with the public interest. The department shall not issue a license to any
             1916      person to prescribe, dispense, or administer a Schedule I controlled substance. In determining
             1917      public interest, the department shall consider whether or not the applicant has:
             1918          (i) maintained effective controls against diversion of controlled substances and any



Text Box

- 63 -
             1919
     Schedule I or II substance compounded from any controlled substance into other than
             1920      legitimate medical, scientific, or industrial channels;
             1921          (ii) complied with applicable state and local law;
             1922          (iii) been convicted under federal or state laws relating to the manufacture, distribution,
             1923      or dispensing of substances;
             1924          (iv) past experience in the manufacture of controlled dangerous substances;
             1925          (v) established effective controls against diversion; and
             1926          (vi) complied with any other factors that the department establishes that promote the
             1927      public health and safety.
             1928          (b) Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,
             1929      produce, distribute, conduct research with, or perform laboratory analysis upon controlled
             1930      substances in Schedule I other than those specified in the license.
             1931          (c) (i) Practitioners shall be licensed to administer, dispense, or conduct research with
             1932      substances in Schedules II through V if they are authorized to administer, dispense, or conduct
             1933      research under the laws of this state.
             1934          (ii) The department need not require a separate license for practitioners engaging in
             1935      research with nonnarcotic controlled substances in Schedules II through V where the licensee is
             1936      already licensed under this act in another capacity.
             1937          (iii) With respect to research involving narcotic substances in Schedules II through V,
             1938      or where the department by rule requires a separate license for research of nonnarcotic
             1939      substances in Schedules II through V, a practitioner shall apply to the department prior to
             1940      conducting research.
             1941          (iv) Licensing for purposes of bona fide research with controlled substances by a
             1942      practitioner considered qualified may be denied only on a ground specified in Subsection (4),
             1943      or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard
             1944      adequately his supply of substances against diversion from medical or scientific use.
             1945          (v) Practitioners registered under federal law to conduct research in Schedule I
             1946      substances may conduct research in Schedule I substances within this state upon furnishing the
             1947      department evidence of federal registration.
             1948          (d) Compliance by manufacturers, producers, and distributors with the provisions of
             1949      federal law respecting registration, excluding fees, entitles them to be licensed under this



Text Box

- 64 -
             1950
     chapter.
             1951          (e) The department shall initially license those persons who own or operate an
             1952      establishment engaged in the manufacture, production, distribution, dispensation, or
             1953      administration of controlled substances prior to April 3, 1980, and who are licensed by the
             1954      state.
             1955          (4) (a) Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed
             1956      on probation, or revoked by the department upon finding that the applicant or licensee has:
             1957          (i) materially falsified any application filed or required pursuant to this chapter;
             1958          (ii) been convicted of an offense under this chapter or any law of the United States, or
             1959      any state, relating to any substance defined as a controlled substance;
             1960          (iii) been convicted of a felony under any other law of the United States or any state
             1961      within five years of the date of the issuance of the license;
             1962          (iv) had a federal license denied, suspended, or revoked by competent federal authority
             1963      and is no longer authorized to engage in the manufacturing, distribution, or dispensing of
             1964      controlled substances;
             1965          (v) had his license suspended or revoked by competent authority of another state for
             1966      violation of laws or regulations comparable to those of this state relating to the manufacture,
             1967      distribution, or dispensing of controlled substances;
             1968          (vi) violated any department rule that reflects adversely on the licensee's reliability and
             1969      integrity with respect to controlled substances;
             1970          (vii) refused inspection of records required to be maintained under this chapter by a
             1971      person authorized to inspect them; or
             1972          (viii) prescribed, dispensed, administered, or injected an anabolic steroid for the
             1973      purpose of manipulating human hormonal structure so as to:
             1974          (A) increase muscle mass, strength, or weight without medical necessity and without a
             1975      written prescription by any practitioner in the course of his professional practice; or
             1976          (B) improve performance in any form of human exercise, sport, or game.
             1977          (b) The department may limit revocation or suspension of a license to a particular
             1978      controlled substance with respect to which grounds for revocation or suspension exist.
             1979          (c) (i) Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to
             1980      this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of



Text Box

- 65 -
             1981
     Occupational and Professional Licensing Act, and conducted in conjunction with the
             1982      appropriate representative committee designated by the director of the department.
             1983          (ii) Nothing in this Subsection (4)(c) gives the Division of Occupational and
             1984      Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,
             1985      except where the department is designated by law to perform those functions, or, when not
             1986      designated by law, is designated by the executive director of the Department of Commerce to
             1987      conduct the proceedings.
             1988          (d) (i) The department may suspend any license simultaneously with the institution of
             1989      proceedings under this section if it finds there is an imminent danger to the public health or
             1990      safety.
             1991          (ii) Suspension shall continue in effect until the conclusion of proceedings, including
             1992      judicial review, unless withdrawn by the department or dissolved by a court of competent
             1993      jurisdiction.
             1994          (e) (i) If a license is suspended or revoked under this Subsection (4), all controlled
             1995      substances owned or possessed by the licensee may be placed under seal in the discretion of the
             1996      department.
             1997          (ii) Disposition may not be made of substances under seal until the time for taking an
             1998      appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,
             1999      orders the sale of perishable substances and the proceeds deposited with the court.
             2000          (iii) If a revocation order becomes final, all controlled substances shall be forfeited.
             2001          (f) The department shall notify promptly the Drug Enforcement Administration of all
             2002      orders suspending or revoking a license and all forfeitures of controlled substances.
             2003          (5) (a) Persons licensed under Subsection (2) or (3) shall maintain records and
             2004      inventories in conformance with the record keeping and inventory requirements of federal and
             2005      state law and any additional rules issued by the department.
             2006          (b) (i) Every physician, dentist, veterinarian, practitioner, or other person who is
             2007      authorized to administer or professionally use a controlled substance shall keep a record of the
             2008      drugs received by him and a record of all drugs administered, dispensed, or professionally used
             2009      by him otherwise than by a prescription.
             2010          (ii) A person using small quantities or solutions or other preparations of those drugs for
             2011      local application has complied with this Subsection (5)(b) if he keeps a record of the quantity,



Text Box

- 66 -
             2012
     character, and potency of those solutions or preparations purchased or prepared by him, and of
             2013      the dates when purchased or prepared.
             2014          (6) Controlled substances in Schedules I through V may be distributed only by a
             2015      licensee and pursuant to an order form prepared in compliance with department rules or a
             2016      lawful order under the rules and regulations of the United States.
             2017          (7) (a) A person may not write or authorize a prescription for a controlled substance
             2018      unless he is:
             2019          (i) a practitioner authorized to prescribe drugs and medicine under the laws of this state
             2020      or under the laws of another state having similar standards; and
             2021          (ii) licensed under this chapter or under the laws of another state having similar
             2022      standards.
             2023          (b) A person other than a pharmacist licensed under the laws of this state, or his
             2024      licensed intern, as required by [Section 58-17a-302 ] Sections 58-17b-303 and 58-17b-304 , may
             2025      not dispense a controlled substance.
             2026          (c) (i) A controlled substance may not be dispensed without the written prescription of
             2027      a practitioner, if the written prescription is required by the federal Controlled Substances Act.
             2028          (ii) That written prescription shall be made in accordance with Subsection (7)(a) and in
             2029      conformity with Subsection (7)(d).
             2030          (iii) In emergency situations, as defined by department rule, controlled substances may
             2031      be dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms
             2032      designated by the department and filed by the pharmacy.
             2033          (iv) Prescriptions reduced to writing by a pharmacist shall be in conformity with
             2034      Subsection (7)(d).
             2035          (d) Except for emergency situations designated by the department, a person may not
             2036      issue, fill, compound, or dispense a prescription for a controlled substance unless the
             2037      prescription is signed in ink or indelible pencil by the prescriber and contains the following
             2038      information:
             2039          (i) the name, address, and registry number of the prescriber;
             2040          (ii) the name, address, and age of the person to whom or for whom the prescription is
             2041      issued;
             2042          (iii) the date of issuance of the prescription; and



Text Box

- 67 -
             2043
         (iv) the name, quantity, and specific directions for use by the ultimate user of the
             2044      controlled substance.
             2045          (e) A prescription may not be written, issued, filled, or dispensed for a Schedule I
             2046      controlled substance.
             2047          (f) Except when administered directly to an ultimate user by a licensed practitioner,
             2048      controlled substances are subject to the following restrictions:
             2049          (i) (A) A prescription for a Schedule II substance may not be refilled.
             2050          (B) A Schedule II controlled substance may not be filled in a quantity to exceed a
             2051      one-month's supply, as directed on the daily dosage rate of the prescriptions.
             2052          (ii) A Schedule III or IV controlled substance may be filled only within six months of
             2053      issuance, and may not be refilled more than six months after the date of its original issuance or
             2054      be refilled more than five times after the date of the prescription unless renewed by the
             2055      practitioner.
             2056          (iii) All other controlled substances in Schedule V may be refilled as the prescriber's
             2057      prescription directs, but they may not be refilled one year after the date the prescription was
             2058      issued unless renewed by the practitioner.
             2059          (iv) Any prescription for a Schedule II substance may not be dispensed if it is not
             2060      presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days
             2061      after the date the prescription was issued, or 30 days after the dispensing date, if that date is
             2062      specified separately from the date of issue.
             2063          (v) A practitioner may issue more than one prescription at the same time for the same
             2064      Schedule II controlled substance, but only under the following conditions:
             2065          (A) no more than three prescriptions for the same Schedule II controlled substance may
             2066      be issued at the same time;
             2067          (B) no one prescription may exceed a 30-day supply;
             2068          (C) a second or third prescription shall include the date of issuance and the date for
             2069      dispensing; and
             2070          (D) unless the practitioner determines there is a valid medical reason to the contrary,
             2071      the date for dispensing a second or third prescription may not be fewer than 30 days from the
             2072      dispensing date of the previous prescription.
             2073          (vi) Each prescription for a controlled substance may contain only one controlled



Text Box

- 68 -
             2074
     substance per prescription form and may not contain any other legend drug or prescription
             2075      item.
             2076          (g) An order for a controlled substance in Schedules II through V for use by an
             2077      inpatient or an outpatient of a licensed hospital is exempt from all requirements of this
             2078      Subsection (7) if the order is:
             2079          (i) issued or made by a prescribing practitioner who holds an unrestricted registration
             2080      with the federal Drug Enforcement Administration, and an active Utah controlled substance
             2081      license in good standing issued by the division under this section, or a medical resident who is
             2082      exempted from licensure under Subsection 58-1-307 (1)(c);
             2083          (ii) authorized by the prescribing practitioner treating the patient and the prescribing
             2084      practitioner designates the quantity ordered;
             2085          (iii) entered upon the record of the patient, the record is signed by the prescriber
             2086      affirming his authorization of the order within 48 hours after filling or administering the order,
             2087      and the patient's record reflects the quantity actually administered; and
             2088          (iv) filled and dispensed by a pharmacist practicing his profession within the physical
             2089      structure of the hospital, or the order is taken from a supply lawfully maintained by the hospital
             2090      and the amount taken from the supply is administered directly to the patient authorized to
             2091      receive it.
             2092          (h) A practitioner licensed under this chapter may not prescribe, administer, or
             2093      dispense a controlled substance to a minor, without first obtaining the consent required in
             2094      Section 78-14-5 of a parent, guardian, or person standing in loco parentis of the minor except
             2095      in cases of an emergency. For purposes of this Subsection (7)(h), "minor" has the same
             2096      meaning as defined in Section 78-3a-103 , and "emergency" means any physical condition
             2097      requiring the administration of a controlled substance for immediate relief of pain or suffering.
             2098          (i) A practitioner licensed under this chapter may not prescribe or administer dosages
             2099      of a controlled substance in excess of medically recognized quantities necessary to treat the
             2100      ailment, malady, or condition of the ultimate user.
             2101          (j) A practitioner licensed under this chapter may not prescribe, administer, or dispense
             2102      any controlled substance to another person knowing that the other person is using a false name,
             2103      address, or other personal information for the purpose of securing the controlled substance.
             2104          (k) A person who is licensed under this chapter to manufacture, distribute, or dispense



Text Box

- 69 -
             2105
     a controlled substance may not manufacture, distribute, or dispense a controlled substance to
             2106      another licensee or any other authorized person not authorized by this license.
             2107          (l) A person licensed under this chapter may not omit, remove, alter, or obliterate a
             2108      symbol required by this chapter or by a rule issued under this chapter.
             2109          (m) A person licensed under this chapter may not refuse or fail to make, keep, or
             2110      furnish any record notification, order form, statement, invoice, or information required under
             2111      this chapter.
             2112          (n) A person licensed under this chapter may not refuse entry into any premises for
             2113      inspection as authorized by this chapter.
             2114          (o) A person licensed under this chapter may not furnish false or fraudulent material
             2115      information in any application, report, or other document required to be kept by this chapter or
             2116      willfully make any false statement in any prescription, order, report, or record required by this
             2117      chapter.
             2118          (8) (a) (i) Any person licensed under this chapter who is found by the department to
             2119      have violated any of the provisions of Subsections (7)(k) through (7)(o) is subject to a penalty
             2120      not to exceed $5,000. The department shall determine the procedure for adjudication of any
             2121      violations in accordance with Sections 58-1-106 and 58-1-108 .
             2122          (ii) The division shall deposit all penalties collected under Subsection (8)(a)(i) in the
             2123      General Fund as a dedicated credit to be used by the division under Subsection 58-37-7.7 (1).
             2124          (b) Any person who knowingly and intentionally violates Subsections (7)(h) through
             2125      (7)(j) is:
             2126          (i) upon first conviction, guilty of a class B misdemeanor;
             2127          (ii) upon second conviction, guilty of a class A misdemeanor; and
             2128          (iii) on third or subsequent conviction, guilty of a third degree felony.
             2129          (c) Any person who knowingly and intentionally violates Subsections (7)(k) through
             2130      (7)(o) shall upon conviction be guilty of a third degree felony.
             2131          (9) Any information communicated to any licensed practitioner in an attempt to
             2132      unlawfully procure, or to procure the administration of, a controlled substance is not considered
             2133      to be a privileged communication.
             2134          Section 53. Section 58-37-7.5 is amended to read:
             2135           58-37-7.5. Controlled substance database -- Advisory committee -- Pharmacy



Text Box

- 70 -
             2136
     reporting requirements -- Access -- Penalties.
             2137          (1) As used in this section:
             2138          (a) "Committee" means the Controlled Substance Database Advisory Committee
             2139      created in this section.
             2140          (b) "Database" means the controlled substance database created in this section.
             2141          (c) "Database manager" means the person responsible for operating the database, or his
             2142      designee.
             2143          (d) "Division" means the Division of Occupational and Professional Licensing created
             2144      in Section 58-1-103 .
             2145          [(e) "Drug outlet" has the same definition as in Section 58-17a-102 .]
             2146          [(f)] (e) "Health care facility" has the same definition as in Section 26-21-2 .
             2147          (f) "Pharmacy or pharmaceutical facility" has the same definition as in Section
             2148      58-17b-102 .
             2149          (2) (a) There is created within the division a controlled substance database.
             2150          (b) The division shall administer and direct the functioning of the database in
             2151      accordance with this section. The division may under state procurement laws contract with
             2152      another state agency or private entity to establish, operate, or maintain the database. The
             2153      division in collaboration with the board shall determine whether to operate the database within
             2154      the division or contract with another entity to operate the database, based on an analysis of
             2155      costs and benefits.
             2156          (c) The purpose of the database is to contain data as described in this section regarding
             2157      every prescription for a controlled substance dispensed in the state to any person other than an
             2158      inpatient in a licensed health care facility.
             2159          (d) Data required by this section shall be submitted in compliance with this section to
             2160      the manager of the database by the pharmacist in charge of the drug outlet where the controlled
             2161      substance is dispensed.
             2162          (3) (a) There is created the Controlled Substance Database Advisory Committee. The
             2163      committee members are:
             2164          (i) two members representing the Utah Medical Association;
             2165          (ii) one member representing the Utah Dental Association;
             2166          (iii) two members representing the Utah Pharmaceutical Association;



Text Box

- 71 -
             2167
         (iv) one member representing the Department of Public Safety;
             2168          (v) one member representing the Utah Association of Chiefs of Police;
             2169          (vi) one member representing the Utah Sheriffs Association;
             2170          (vii) one member representing the state Office of the Attorney General;
             2171          (viii) one member representing the Statewide Association of Public Attorneys; and
             2172          (ix) three members representing the general public, and who are not health care
             2173      providers.
             2174          (b) The committee shall be appointed and serve in accordance with Section 58-1-201 .
             2175          (c) The committee shall advise the division regarding:
             2176          (i) establishing, maintaining, and operating the database;
             2177          (ii) access to the database and how access is obtained; and
             2178          (iii) control of information contained in the database.
             2179          (4) The pharmacist in charge shall, regarding each controlled substance dispensed by a
             2180      pharmacist under his supervision other than those dispensed for an inpatient at a health care
             2181      facility, submit to the manager of the database the following information, by a procedure and in
             2182      a format established by the division:
             2183          (a) name of the prescribing practitioner;
             2184          (b) date of the prescription;
             2185          (c) date the prescription was filled;
             2186          (d) name of the person for whom the prescription was written;
             2187          (e) positive identification of the person receiving the prescription, including the type of
             2188      identification and any identifying numbers on the identification;
             2189          (f) name of the controlled substance;
             2190          (g) quantity of controlled substance prescribed;
             2191          (h) strength of controlled substance;
             2192          (i) quantity of controlled substance dispensed;
             2193          (j) dosage quantity and frequency as prescribed;
             2194          (k) name of drug outlet dispensing the controlled substance;
             2195          (l) name of pharmacist dispensing the controlled substance; and
             2196          (m) other relevant information as required by division rule.
             2197          (5) The division shall maintain the database in an electronic file or by other means



Text Box

- 72 -
             2198
     established by the division to facilitate use of the database for identification of:
             2199          (a) prescribing practices and patterns of prescribing and dispensing controlled
             2200      substances;
             2201          (b) practitioners prescribing controlled substances in an unprofessional or unlawful
             2202      manner;
             2203          (c) individuals receiving prescriptions for controlled substances from licensed
             2204      practitioners, and who subsequently obtain dispensed controlled substances from a drug outlet
             2205      in quantities or with a frequency inconsistent with generally recognized standards of dosage for
             2206      that controlled substance; and
             2207          (d) individuals presenting forged or otherwise false or altered prescriptions for
             2208      controlled substances to a [drug outlet] pharmacy.
             2209          (6) (a) The division shall by rule establish the electronic format in which the
             2210      information required under this section shall be submitted to the administrator of the database.
             2211          (b) The division shall ensure the database system records and maintains for reference:
             2212          (i) identification of each person who requests or receives information from the
             2213      database;
             2214          (ii) the information provided to each person; and
             2215          (iii) the date and time the information is requested or provided.
             2216          (7) The division shall make rules in collaboration with the committee to:
             2217          (a) effectively enforce the limitations on access to the database as described in
             2218      Subsection (8); and
             2219          (b) establish standards and procedures to ensure accurate identification of individuals
             2220      requesting information or receiving information without request from the database.
             2221          (8) The manager of the database shall make information in the database available only
             2222      to the following persons, and in accordance with the limitations stated and division rules:
             2223          (a) personnel of the division specifically assigned to conduct investigations related to
             2224      controlled substances laws under the jurisdiction of the division;
             2225          (b) authorized division personnel engaged in analysis of controlled substance
             2226      prescription information as a part of the assigned duties and responsibilities of their
             2227      employment;
             2228          (c) a licensed practitioner having authority to prescribe controlled substances, to the



Text Box

- 73 -
             2229
     extent the information relates specifically to a current patient of the practitioner, to whom the
             2230      practitioner is prescribing or considering prescribing any controlled substance;
             2231          (d) a licensed pharmacist having authority to dispense controlled substances to the
             2232      extent the information relates specifically to a current patient to whom that pharmacist is
             2233      dispensing or considering dispensing any controlled substance;
             2234          (e) federal, state, and local law enforcement authorities engaged as a specified duty of
             2235      their employment in enforcing laws regulating controlled substances; and
             2236          (f) an individual who is the recipient of a controlled substance prescription entered into
             2237      the database, upon providing evidence satisfactory to the database manager that the individual
             2238      requesting the information is in fact the person about whom the data entry was made.
             2239          (9) Any person who knowingly and intentionally releases any information in the
             2240      database in violation of the limitations under Subsection (8) is guilty of a third degree felony.
             2241          (10) Any person who obtains or attempts to obtain information from the database by
             2242      misrepresentation or fraud is guilty of a third degree felony.
             2243          (11) (a) A person may not knowingly and intentionally use, release, publish, or
             2244      otherwise make available to any other person or entity any information obtained from the
             2245      database for any purpose other than those specified in Subsection (8). Each separate violation
             2246      of this Subsection (11) is a third degree felony and is also subject to a civil penalty not to
             2247      exceed $5,000.
             2248          (b) The procedure for determining a civil violation of this Subsection (11) shall be in
             2249      accordance with Section 58-1-108 , regarding adjudicative proceedings within the division.
             2250          (c) Civil penalties assessed under this Subsection (11) shall be deposited in the General
             2251      Fund as a dedicated credit to be used by the division under Subsection 58-37-7.7 (1).
             2252          (12) (a) The failure of a pharmacist in charge to submit information to the database as
             2253      required under this section after the division has submitted a specific written request for the
             2254      information or when the division determines the individual has a demonstrable pattern of
             2255      failing to submit the information as required is grounds for the division to take the following
             2256      actions in accordance with Section 58-1-401 :
             2257          (i) refuse to issue a license to the individual;
             2258          (ii) refuse to renew the individual's license;
             2259          (iii) revoke, suspend, restrict, or place on probation the license;



Text Box

- 74 -
             2260
         (iv) issue a public or private reprimand to the individual;
             2261          (v) issue a cease and desist order; and
             2262          (vi) impose a civil penalty of not more than $1,000 for each dispensed prescription
             2263      regarding which the required information is not submitted.
             2264          (b) Civil penalties assessed under Subsection (12)(a)(vi) shall be deposited in the
             2265      General Fund as a dedicated credit to be used by the division under Subsection 58-37-7.7 (1).
             2266          (c) The procedure for determining a civil violation of this Subsection (12) shall be in
             2267      accordance with Section 58-1-108 , regarding adjudicative proceedings within the division.
             2268          (13) An individual who has submitted information to the database in accordance with
             2269      this section may not be held civilly liable for having submitted the information.
             2270          (14) All department and the division costs necessary to establish and operate the
             2271      database shall be funded by appropriations from:
             2272          (a) the Commerce Service Fund; and
             2273          (b) the General Fund.
             2274          (15) All costs associated with recording and submitting data as required in this section
             2275      shall be assumed by the submitting [drug outlet] pharmacy.
             2276          Section 54. Section 58-37c-19.5 is amended to read:
             2277           58-37c-19.5. Iodine solution greater than 1.5% -- Prescription or permit required
             2278      -- Penalties.
             2279          (1) As used in this section, "iodine matrix" means iodine at concentrations greater than
             2280      1.5% by weight in a matrix or solution.
             2281          (2) A person may offer to sell, sell, or distribute an iodine matrix only:
             2282          (a) as a prescription drug, pursuant to a prescription issued by a veterinarian or
             2283      physician licensed within the state; or
             2284          (b) to a person who is actively engaged in the legal practice of animal husbandry of
             2285      livestock, as defined in Section 4-1-8 .
             2286          (3) Prescriptions issued under this section:
             2287          (a) shall provide for a specified number of refills;
             2288          (b) may be issued by electronic means, in accordance with Title 58, Chapter [17a] 17b,
             2289      Pharmacy Practice Act; and
             2290          (c) may be filled by a person other than the veterinarian or physician issuing the



Text Box

- 75 -
             2291
     prescription.
             2292          (4) A retailer offering iodine matrix for sale:
             2293          (a) shall store the iodine matrix so that the public does not have access to the iodine
             2294      matrix without the direct assistance or intervention of a retail employee;
             2295          (b) shall keep a record, which may consist of sales receipts, of each person purchasing
             2296      iodine matrix; and
             2297          (c) may, if necessary to ascertain the identity of the purchaser, ask for proof of
             2298      identification from the purchaser.
             2299          (5) A person engaging in a regulated transaction under Subsection (2) is guilty of a
             2300      class B misdemeanor if the person, under circumstances not amounting to a violation of
             2301      Subsection 58-37d-4 (1)(c), offers to sell, sells, or distributes an iodine matrix to a person who:
             2302          (a) does not present a prescription or is not engaged in animal husbandry, as required
             2303      under Subsection (2); or
             2304          (b) is not excepted under Subsection (7).
             2305          (6) A person is guilty of a class A misdemeanor who, under circumstances not
             2306      amounting to a violation of Subsection 58-37c-3 (12)(k) or 58-37d-4 (1)(a):
             2307          (a) possesses an iodine matrix without proof of obtaining the solution in compliance
             2308      with Subsection (2); or
             2309          (b) offers to sell, sells, or distributes an iodine matrix in violation of Subsection (2).
             2310          (7) Subsection (6)(a) does not apply to:
             2311          (a) a chemistry or chemistry-related laboratory maintained by:
             2312          (i) a public or private regularly established secondary school; or
             2313          (ii) a public or private institution of higher education that is accredited by a regional or
             2314      national accrediting agency recognized by the United States Department of Education;
             2315          (b) a veterinarian licensed to practice under Title 58, Chapter 28, Veterinary Practice
             2316      Act;
             2317          (c) a general acute hospital; or
             2318          (d) a veterinarian, physician, pharmacist, retail distributor, wholesaler, manufacturer,
             2319      warehouseman, or common carrier, or an agent of any of these persons who possesses an
             2320      iodine matrix in the regular course of lawful business activities.
             2321          Section 55. Section 58-71-102 is amended to read:



Text Box

- 76 -
             2322
          58-71-102. Definitions.
             2323          In addition to the definitions in Section 58-1-102 , as used in this chapter:
             2324          (1) "Administrative penalty" means a monetary fine imposed by the division for acts or
             2325      omissions determined to constitute unprofessional or unlawful conduct, as a result of an
             2326      adjudicative proceeding conducted in accordance with Title 63, Chapter 46b, Administrative
             2327      Procedures Act.
             2328          (2) "Acupuncture" has the same definition as in Section 58-72-102 .
             2329          (3) "Board" means the Naturopathic Physicians Licensing Board created in Section
             2330      58-71-201 .
             2331          (4) "Diagnose" means:
             2332          (a) to examine in any manner another person, parts of a person's body, substances,
             2333      fluids, or materials excreted, taken, or removed from a person's body, or produced by a person's
             2334      body, to determine the source, nature, kind, or extent of a disease or other physical or mental
             2335      condition;
             2336          (b) to attempt to conduct an examination or determination described under Subsection
             2337      (4)(a); [or]
             2338          (c) to hold oneself out as making or to represent that one is making an examination or
             2339      determination as described in Subsection (4)(a); or
             2340          (d) to make an examination or determination as described in Subsection (4)(a) upon or
             2341      from information supplied directly or indirectly by another person, whether or not in the
             2342      presence of the person making or attempting the diagnosis or examination.
             2343          (5) "Local anesthesia" means an agent, whether a natural medicine or prescription drug,
             2344      which:
             2345          (a) is applied topically or by injection in superficial tissues associated with the
             2346      performance of minor office procedures;
             2347          (b) has the ability to produce loss of sensation at the site of minor office procedures;
             2348      and
             2349          (c) does not cause loss of consciousness or produce general sedation.
             2350          (6) "Medical naturopathic assistant" means an unlicensed individual working under the
             2351      direct and immediate supervision of a licensed naturopathic physician and engaged in specific
             2352      tasks assigned by the licensed naturopathic physician in accordance with the standards and



Text Box

- 77 -
             2353
     ethics of the profession.
             2354          (7) (a) "Minor office procedures" means:
             2355          (i) the use of operative, electrical, or other methods for repair and care of superficial
             2356      lacerations, abrasions, and benign lesions;
             2357          (ii) removal of foreign bodies located in the superficial tissues, excluding the eye or
             2358      ear; and
             2359          (iii) the use of antiseptics and local anesthetics in connection with minor office surgical
             2360      procedures; and
             2361          (b) "Minor office procedures" does not include:
             2362          (i) general or spinal anesthesia;
             2363          (ii) office procedures more complicated or extensive than those set forth in Subsection
             2364      (7)(a);
             2365          (iii) procedures involving the eye; or
             2366          (iv) any office procedure involving tendons, nerves, veins, or arteries.
             2367          (8) "Natural medicine" means:
             2368          (a) food, food extracts, dietary supplements as defined by the federal Food, Drug, and
             2369      Cosmetics Act, all homeopathic remedies, and plant substances that are not designated as
             2370      prescription drugs or controlled substances;
             2371          (b) over-the-counter medications;
             2372          (c) other nonprescription substances, the prescription or administration of which is not
             2373      otherwise prohibited or restricted under federal or state law; and
             2374          (d) prescription drugs:
             2375          (i) that are not controlled substances as defined in Section 58-37-2 ;
             2376          (ii) the prescription of which is consistent with the competent practice of naturopathic
             2377      medicine; and
             2378          (iii) the prescription of which is approved by the division in collaboration with the
             2379      naturopathic formulary advisory peer committee.
             2380          (9) (a) "Naturopathic childbirth" means uncomplicated natural childbirth assisted by a
             2381      naturopathic physician, and includes the use of:
             2382          (i) natural medicines; and
             2383          (ii) uncomplicated episiotomy.



Text Box

- 78 -
             2384
         (b) "Naturopathic childbirth" does not include the use of:
             2385          (i) forceps delivery;
             2386          (ii) general or spinal anesthesia;
             2387          (iii) caesarean section delivery; or
             2388          (iv) induced labor or abortion.
             2389          (10) "Naturopathic mobilization therapy":
             2390          (a) means manually administering mechanical treatment of body structures or tissues
             2391      for the purpose of restoring normal physiological function to the body by normalizing and
             2392      balancing the musculoskeletal system of the body;
             2393          (b) does not mean manipulation or adjustment of the joints of the human body beyond
             2394      the elastic barrier; and
             2395          (c) does not include manipulation as defined in Title 58, Chapter 73, Chiropractic
             2396      Physician Practice Act.
             2397          (11) "Naturopathic physical medicine" means the use of the physical agents of air,
             2398      water, heat, cold, sound, light, and electromagnetic nonionizing radiation, and the physical
             2399      modalities of electrotherapy, biofeedback, acupuncture, diathermy, ultraviolet light, ultrasound,
             2400      hydrotherapy, naturopathic mobilization therapy, and exercise. Naturopathic medicine does not
             2401      include the practice of physical therapy or physical rehabilitation.
             2402          (12) "Practice of naturopathic medicine" means:
             2403          (a) a system of primary health care for the prevention, diagnosis, and treatment of
             2404      human health conditions, injuries, and diseases that uses education, natural medicines, and
             2405      natural therapies, to support and stimulate the patient's intrinsic self-healing processes:
             2406          (i) using naturopathic childbirth, but only if:
             2407          (A) the licensee meets standards of the American College of Naturopathic
             2408      Obstetricians (ACNO) or its successor as determined by the division in collaboration with the
             2409      board; and
             2410          (B) the licensee follows a written plan for naturopathic physicians practicing
             2411      naturopathic childbirth approved by the division in collaboration with the board, which
             2412      includes entering into an agreement with a consulting physician and surgeon or osteopathic
             2413      physician, in cases where the scope of practice of naturopathic childbirth may be exceeded and
             2414      specialty care and delivery is indicated, detailing the guidelines by which the naturopathic



Text Box

- 79 -
             2415
     physician will:
             2416          (I) refer patients to the consulting physician; and
             2417          (II) consult with the consulting physician;
             2418          (ii) using naturopathic mobilization therapy;
             2419          (iii) using naturopathic physical medicine;
             2420          (iv) using minor office procedures;
             2421          (v) prescribing or administering natural medicine;
             2422          (vi) prescribing medical equipment and devices, diagnosing by the use of medical
             2423      equipment and devices, and administering therapy or treatment by the use of medical devices
             2424      necessary and consistent with the competent practice of naturopathic medicine;
             2425          (vii) prescribing barrier devices for contraception;
             2426          (viii) using dietary therapy;
             2427          (ix) taking and using diagnostic x-rays, electrocardiograms, ultrasound, and
             2428      physiological function tests;
             2429          (x) taking of body fluids for clinical laboratory tests and using the results of the tests in
             2430      diagnosis;
             2431          (xi) taking of a history from and conducting of a physical examination upon a human
             2432      patient; and
             2433          (xii) prescribing and administering natural medicines and medical devices, except a
             2434      naturopathic physician may only administer:
             2435          (A) a prescription drug, as defined in Section [ 58-17a-102 ] 58-17b-102 , in accordance
             2436      with Subsection (8)(d); and
             2437          (B) local anesthesia that is not a controlled substance, and only in the performance of
             2438      minor office procedures;
             2439          (b) to maintain an office or place of business for the purpose of doing any of the acts
             2440      described in Subsection (12)(a), whether or not for compensation; or
             2441          (c) to use, in the conduct of any occupation or profession pertaining to the diagnosis or
             2442      treatment of human diseases or conditions, in any printed material, stationery, letterhead,
             2443      envelopes, signs, or advertisements, the designation "naturopathic physician," "naturopathic
             2444      doctor," "naturopath," "doctor of naturopathic medicine," "doctor of naturopathy,"
             2445      "naturopathic medical doctor," "naturopathic medicine," "naturopathic health care,"



Text Box

- 80 -
             2446
     "naturopathy," "N.D.," "N.M.D.," or any combination of these designations in any manner that
             2447      might cause a reasonable person to believe the individual using the designation is a licensed
             2448      naturopathic physician.
             2449          (13) "Prescription drug or device" means:
             2450          (a) a drug or device which, under federal law, is required to be labeled with either of
             2451      the following statements or their equivalent:
             2452          (i) "CAUTION: Federal law prohibits dispensing without prescription"; or
             2453          (ii) "CAUTION: Federal law restricts this drug to use by or on the order of a licensed
             2454      veterinarian"; or
             2455          (b) a drug or device that is required by any applicable federal or state law or rule to be
             2456      dispensed on prescription only or is restricted to use by practitioners only.
             2457          (14) "Unlawful conduct" is as defined in Sections 58-1-501 and 58-71-501 .
             2458          (15) "Unprofessional conduct" is as defined in Sections 58-1-501 and 58-71-502 , and
             2459      as may be further defined by division rule.
             2460          Section 56. Section 58-71-801 is amended to read:
             2461           58-71-801. Disclosure of financial interest by licensee.
             2462          (1) Except as provided in Subsection (2), licensees under this chapter may not own,
             2463      directly or indirectly:
             2464          (a) any [drug outlet] pharmacy or pharmaceutical facility as defined in Section
             2465      [ 58-17a-102 ] 58-17b-102 ; or
             2466          (b) a retail store, wholesaler, distributor, manufacturer, or facility of any other kind
             2467      located in this state that is engaged in the sale, dispensing, delivery, distribution, or
             2468      manufacture of homeopathic remedies, dietary supplements, or natural medicines.
             2469          (2) A licensee may own or control less than 5% of the outstanding stock of a
             2470      corporation whose ownership is prohibited under Subsection (1), if the stock of the corporation
             2471      is publicly traded.
             2472          (3) Licensees under this chapter may not refer patients, clients, or customers to any
             2473      clinical laboratory, ambulatory or surgical care facilities, or other treatment or rehabilitation
             2474      services such as physical therapy, cardiac rehabilitation, or radiology services in which the
             2475      licensee or a member of the licensee's immediate family has any financial relationship as that
             2476      term is described in 42 U.S.C. 1395nn, unless the licensee at the time of making the referral



Text Box

- 81 -
             2477
     discloses that relationship, in writing, to the patient, client, or customer.
             2478          (4) The written disclosure under Subsection [(1)] (3) shall also state the patient may
             2479      choose any facility or service center for purpose of having the laboratory work or treatment
             2480      service performed.
             2481          (5) Licensees under this chapter may not sell from their offices homeopathic remedies
             2482      or dietary supplements, as defined in the Federal Food Drug and Cosmetic Act, except for
             2483      those products that are not readily available from other local sources.
             2484          Section 57. Section 58-73-601 is amended to read:
             2485           58-73-601. Scope of practice for a chiropractic physician.
             2486          (1) A chiropractic physician licensed under this chapter may engage in the practice of
             2487      chiropractic as defined in Section 58-73-102 in accordance with the following standards.
             2488          (2) A chiropractic physician may:
             2489          (a) examine, diagnose, and treat only within the scope of chiropractic as described in
             2490      this Subsection (2);
             2491          (b) use x-ray for diagnostic purposes only;
             2492          (c) administer:
             2493          (i) physical agents, including light, heat, cold, water, air, sound, compression,
             2494      electricity, and electromagnetic radiation except gamma radiation; and
             2495          (ii) physical activities and devices, including:
             2496          (A) exercise with and without devices;
             2497          (B) joint mobilization;
             2498          (C) mechanical stimulation;
             2499          (D) postural drainage;
             2500          (E) traction;
             2501          (F) positioning;
             2502          (G) wound debridement, cleansing, and dressing changes;
             2503          (H) splinting;
             2504          (I) training in locomotion and other functional activities with and without assistance
             2505      devices; and
             2506          (J) correction of posture, body mechanics, and gait;
             2507          (d) administer the following topically applied medicinal agents, including steroids,



Text Box

- 82 -
             2508
     anesthetics, coolants, and analgesics for wound care and for musculoskeletal treatment,
             2509      including their use by iontophoresis or phonophoresis;
             2510          (e) treat pain incident to major or minor surgery, cancer, obstetrics, or x-ray therapy;
             2511          (f) utilize immobilizing appliances, casts, and supports for support purposes, but may
             2512      not set displaced bone fractures;
             2513          (g) inform the patient of possible side effects of medication and recommend referral to
             2514      the prescribing practitioner;
             2515          (h) provide instruction in the use of physical measures, activities, and devices for
             2516      preventive and therapeutic purposes;
             2517          (i) provide consulting, educational, and other advisory services for the purposes of
             2518      reducing the incidence and severity of physical disability, movement dysfunctions, bodily
             2519      malfunction, and pain;
             2520          (j) treat a human being to assess, prevent, correct, alleviate, and limit physical
             2521      disability, movement dysfunction, bodily malfunction, and pain resulting from disorders,
             2522      congenital and aging conditions, injury, and disease; and
             2523          (k) administer, interpret, and evaluate tests.
             2524          (3) A chiropractic physician may not:
             2525          (a) perform incisive surgery;
             2526          (b) administer drugs or medicines for which an authorized prescription is required by
             2527      law except as provided in Subsection (2)(d);
             2528          (c) treat cancer;
             2529          (d) practice obstetrics;
             2530          (e) prescribe or administer x-ray therapy; or
             2531          (f) set displaced fractures.
             2532          (4) A chiropractic physician shall assume responsibility for his examinations,
             2533      diagnoses, and treatment.
             2534          (5) Nothing in this section authorizes a chiropractic physician to prescribe, possess for
             2535      dispensing, dispense, purchase without a prescription written by a licensed and authorized
             2536      practitioner, or administer, except under Subsection (2)(d), a drug requiring a prescription to
             2537      dispense, under Title 58, Chapter 37, Utah Controlled Substances Act, or Title 58, Chapter
             2538      [17a] 17b, Pharmacy Practice Act.



Text Box

- 83 -
             2539
         (6) Only primary health care providers licensed under this title as osteopathic
             2540      physicians, physicians and surgeons, naturopaths, and chiropractic physicians, may diagnose,
             2541      adjust, manipulate, or therapeutically position the articulation of the spinal column to the extent
             2542      permitted by their scopes of practice.
             2543          Section 58. Section 63-55-258 is amended to read:
             2544           63-55-258. Repeal dates, Title 58.
             2545          (1) Title 58, Chapter 3a, Architects Licensing Act, is repealed July 1, 2013.
             2546          (2) Title 58, Chapter 5a, Podiatric Physician Licensing Act, is repealed July 1, 2007.
             2547          (3) Title 58, Chapter 9, Funeral Services Licensing Act, is repealed July 1, 2008.
             2548          (4) Title 58, Chapter 13, Health Care Providers Immunity from Liability Act, is
             2549      repealed July 1, 2006.
             2550          (5) Title 58, Chapter 15, Health Facility Administrator Act, is repealed July 1, 2005.
             2551          (6) Title 58, Chapter 16a, Utah Optometry Practice Act, is repealed July 1, 2009.
             2552          (7) Title 58, Chapter [17a] 17b, Pharmacy Practice Act, is repealed July 1, [2006]
             2553      2014.
             2554          (8) Title 58, Chapter 20a, Environmental Health Scientist Act, is repealed July 1, 2013.
             2555          (9) Title 58, Chapter 22, Professional Engineers and Professional Land Surveyors
             2556      Licensing Act, is repealed July 1, 2005.
             2557          (10) Title 58, Chapter 24a, Physical Therapist Practice Act, is repealed July 1, 2013.
             2558          (11) Title 58, Chapter 26a, Certified Public Accountant Licensing Act, is repealed July
             2559      1, 2007.
             2560          (12) Title 58, Chapter 28, Veterinary Practice Act, is repealed July 1, 2004.
             2561          (13) Title 58, Chapter 31b, Nurse Practice Act, is repealed July 1, 2005.
             2562          (14) Title 58, Chapter 37, Utah Controlled Substances Act, is repealed July 1, 2007.
             2563          (15) Title 58, Chapter 37a, Utah Drug Paraphernalia Act, is repealed July 1, 2007.
             2564          (16) Title 58, Chapter 37b, Imitation Controlled Substances Act, is repealed July 1,
             2565      2007.
             2566          (17) Title 58, Chapter 40, Recreational Therapy Practice Act, is repealed July 1, 2005.
             2567          (18) Title 58, Chapter 41, Speech-language Pathology and Audiology Licensing Act, is
             2568      repealed July 1, 2009.
             2569          (19) Title 58, Chapter 42a, Occupational Therapy Practice Act, is repealed July 1,



Text Box

- 84 -
             2570
     2005.
             2571          (20) Title 58, Chapter 44a, Nurse Midwife Practice Act, is repealed July 1, 2010.
             2572          (21) Title 58, Chapter 46a, Hearing Instrument Specialist Licensing Act, is repealed
             2573      July 1, 2013.
             2574          (22) Title 58, Chapter 47b, Massage Therapy Practice Act, is repealed July 1, 2004.
             2575          (23) Title 58, Chapter 49, Dietitian Certification Act, is repealed July 1, 2005.
             2576          (24) Title 58, Chapter 53, Landscape Architects Licensing Act, is repealed July 1,
             2577      2008.
             2578          (25) Title 58, Chapter 59, Professional Employer Organization Licensing Act, is
             2579      repealed July 1, 2007.
             2580          (26) Title 58, Chapter 67, Utah Medical Practice Act, is repealed July 1, 2006.
             2581          (27) Title 58, Chapter 68, Utah Osteopathic Medical Practice Act, is repealed July 1,
             2582      2006.
             2583          (28) Title 58, Chapter 69, Dentist and Dental Hygienist Practice Act, is repealed July 1,
             2584      2006.
             2585          (29) Title 58, Chapter 71, Naturopathic Physician Practice Act, is repealed July 1,
             2586      2006.
             2587          (30) Title 58, Chapter 72, Acupuncture Licensing Act, is repealed July 1, 2007.
             2588          (31) Title 58, Chapter 73, Chiropractic Physician Practice Act, is repealed July 1, 2006.
             2589          Section 59. Section 76-5-113 is amended to read:
             2590           76-5-113. Surreptitious administration of certain substances -- Definitions --
             2591      Penalties -- Defenses.
             2592          (1) As used in this section:
             2593          (a) "Administer" means the introduction of a substance into the body by injection,
             2594      inhalation, ingestion, or by any other means.
             2595          (b) "Alcoholic beverage" has the same meaning as "alcoholic beverages" in Section
             2596      32A-1-105 .
             2597          (c) "Bodily injury" has the same definition as in Section 76-1-601 .
             2598          (d) "Controlled substance" has the same definition as in Section 58-37-2 .
             2599          (e) "Deleterious substance" means a substance which, if administered, would likely
             2600      cause bodily injury.



Text Box

- 85 -
             2601
         (f) "Poisonous" means a substance which, if administered, would likely cause serious
             2602      bodily injury or death.
             2603          (g) "Prescription drug" has the same definition as in Section [ 58-17a-102 ] 58-17b-102 .
             2604          (h) "Serious bodily injury" has the same definition as in Section 19-2-115 .
             2605          (i) "Substance" means a controlled substance, poisonous substance, or deleterious
             2606      substance as defined in this Subsection (1).
             2607          (2) In addition to any other offense the actor's conduct may constitute, it is a criminal
             2608      offense for a person, surreptitiously or by means of fraud, deception, or misrepresentation, to
             2609      cause another person to unknowingly consume or receive the administration of:
             2610          (a) any poisonous, deleterious, or controlled substance; or
             2611          (b) any alcoholic beverage.
             2612          (3) A violation of Subsection (2) is:
             2613          (a) a second degree felony if the substance is a poisonous substance, regardless of
             2614      whether the substance is a controlled substance or a prescription drug;
             2615          (b) a third degree felony if the substance is not within the scope of Subsection (3)(a),
             2616      and is a controlled substance or a prescription drug; and
             2617          (c) a class A misdemeanor if the substance is a deleterious substance or an alcoholic
             2618      beverage.
             2619          (4) (a) It is an affirmative defense to a prosecution under Subsection (2) that the actor:
             2620          (i) provided the appropriate administration of a prescription drug; and
             2621          (ii) acted on the reasonable belief that his conduct was in the best interest of the
             2622      well-being of the person to whom the prescription drug was administered.
             2623          (b) (i) The defendant shall file and serve on the prosecuting attorney a notice in writing
             2624      of his intention to claim a defense under Subsection (4)(a) not fewer than 20 days before the
             2625      trial.
             2626          (ii) The notice shall specifically identify the factual basis for the defense and the names
             2627      and addresses of the witnesses the defendant proposes to examine to establish the defense.
             2628          (c) The prosecuting attorney shall file and serve the defendant with a notice containing
             2629      the names and addresses of the witnesses the prosecutor proposes to examine in order to
             2630      contradict or rebut the defendant's claim of an affirmative defense under Subsection (4)(a).
             2631      This notice shall be filed or served not more than ten days after receipt of the defendant's notice



Text Box

- 86 -
             2632
     under Subsection (4)(b), or at another time as the court may direct.
             2633          (d) (i) Failure of a party to comply with the requirements of Subsection (4)(b) or (4)(c)
             2634      entitles the opposing party to a continuance to allow for preparation.
             2635          (ii) If the court finds that a party's failure to comply is the result of bad faith, it may
             2636      impose appropriate sanctions.
             2637          (5) This section does not diminish the scope of authorized health care by a health care
             2638      provider as defined in Section 26-23a-1 .
             2639          Section 60. Section 76-8-311.3 is amended to read:
             2640           76-8-311.3. Items prohibited in correctional and mental health facilities --
             2641      Penalties.
             2642          (1) As used in this section:
             2643          (a) "Contraband" means any item not specifically prohibited for possession by
             2644      offenders under this section or Title 58, Chapter 37, Utah Controlled Substances Act.
             2645          (b) "Controlled substance" means any substance defined as a controlled substance
             2646      under Title 58, Chapter 37, Utah Controlled Substances Act.
             2647          (c) "Correctional facility" means:
             2648          (i) any facility operated by or contracting with the Department of Corrections to house
             2649      offenders in either a secure or nonsecure setting;
             2650          (ii) any facility operated by a municipality or a county to house or detain criminal
             2651      offenders;
             2652          (iii) any juvenile detention facility; and
             2653          (iv) any building or grounds appurtenant to the facility or lands granted to the state,
             2654      municipality, or county for use as a correctional facility.
             2655          (d) "Medicine" means any prescription drug as defined in Title 58, Chapter [17a] 17b,
             2656      Pharmacy Practice Act, but does not include any controlled substances as defined in Title 58,
             2657      Chapter 37, Utah Controlled Substances Act.
             2658          (e) "Mental health facility" has the same meaning as defined in Section 62A-15-602 .
             2659          (f) "Offender" means a person in custody at a correctional facility.
             2660          (g) "Secure area" has the same meaning as provided in Section 76-8-311.1 .
             2661          (2) Notwithstanding Section 76-10-500 , a correctional or mental health facility may
             2662      provide by rule that no firearm, ammunition, dangerous weapon, implement of escape,



Text Box

- 87 -
             2663
     explosive, controlled substance, spirituous or fermented liquor, medicine, or poison in any
             2664      quantity may be:
             2665          (a) transported to or upon a correctional or mental health facility;
             2666          (b) sold or given away at any correctional or mental health facility;
             2667          (c) given to or used by any offender at a correctional or mental health facility; or
             2668          (d) knowingly or intentionally possessed at a correctional or mental health facility.
             2669          (3) It is a defense to any prosecution under this section if the accused in committing the
             2670      act made criminal by this section:
             2671          (a) with respect to a correctional facility operated by the Department of Corrections,
             2672      acted in conformity with departmental rule or policy;
             2673          (b) with respect to a correctional facility operated by a municipality, acted in
             2674      conformity with the policy of the municipality;
             2675          (c) with respect to a correctional facility operated by a county, acted in conformity with
             2676      the policy of the county; or
             2677          (d) with respect to a mental health facility, acted in conformity with the policy of the
             2678      mental health facility.
             2679          (4) (a) Any person who transports to or upon a correctional facility, or into a secure
             2680      area of a mental health facility, any firearm, ammunition, dangerous weapon, or implement of
             2681      escape with intent to provide or sell it to any offender, is guilty of a second degree felony.
             2682          (b) Any person who provides or sells to any offender at a correctional facility, or any
             2683      detainee at a secure area of a mental health facility, any firearm, ammunition, dangerous
             2684      weapon, or implement of escape is guilty of a second degree felony.
             2685          (c) Any offender who possesses at a correctional facility, or any detainee who
             2686      possesses at a secure area of a mental health facility, any firearm, ammunition, dangerous
             2687      weapon, or implement of escape is guilty of a second degree felony.
             2688          (d) Any person who, without the permission of the authority operating the correctional
             2689      facility or the secure area of a mental health facility, knowingly possesses at a correctional
             2690      facility or a secure area of a mental health facility any firearm, ammunition, dangerous weapon,
             2691      or implement of escape is guilty of a third degree felony.
             2692          (e) Any person violates Section 76-10-306 who knowingly or intentionally transports,
             2693      possesses, distributes, or sells any explosive in a correctional facility or mental health facility.



Text Box

- 88 -
             2694
         (5) (a) A person is guilty of a third degree felony who, without the permission of the
             2695      authority operating the correctional facility or secure area of a mental health facility, knowingly
             2696      transports to or upon a correctional facility or into a secure area of a mental health facility any:
             2697          (i) spirituous or fermented liquor;
             2698          (ii) medicine, whether or not lawfully prescribed for the offender; or
             2699          (iii) poison in any quantity.
             2700          (b) A person is guilty of a third degree felony who knowingly violates correctional or
             2701      mental health facility policy or rule by providing or selling to any offender at a correctional
             2702      facility or detainee within a secure area of a mental health facility any:
             2703          (i) spirituous or fermented liquor;
             2704          (ii) medicine, whether or not lawfully prescribed for the offender; or
             2705          (iii) poison in any quantity.
             2706          (c) An inmate is guilty of a third degree felony who, in violation of correctional or
             2707      mental health facility policy or rule, possesses at a correctional facility or in a secure area of a
             2708      mental health facility any:
             2709          (i) spirituous or fermented liquor;
             2710          (ii) medicine, other than medicine provided by the facility's health care providers in
             2711      compliance with facility policy; or
             2712          (iii) poison in any quantity.
             2713          (d) A person is guilty of a class A misdemeanor who, without the permission of the
             2714      authority operating the correctional or mental health facility, fails to declare or knowingly
             2715      possesses at a correctional facility or in a secure area of a mental health facility any:
             2716          (i) spirituous or fermented liquor;
             2717          (ii) medicine; or
             2718          (iii) poison in any quantity.
             2719          (e) A person is guilty of a class B misdemeanor who, without the permission of the
             2720      authority operating the facility, knowingly engages in any activity that would facilitate the
             2721      possession of any contraband by an offender in a correctional facility.
             2722          (f) Exemptions may be granted for worship for Native American inmates pursuant to
             2723      Section 64-13-40 .
             2724          (6) The possession, distribution, or use of a controlled substance at a correctional



Text Box

- 89 -
             2725
     facility or in a secure area of a mental health facility shall be prosecuted in accordance with
             2726      Title 58, Chapter 37, Utah Controlled Substances Act.
             2727          Section 61. Section 78-11-22.2 is amended to read:
             2728           78-11-22.2. Donation of nonschedule drugs or devices -- Liability limitation.
             2729          (1) As used in this section:
             2730          (a) "Administer" is as defined in Section [ 58-17a-102 ] 58-17b-102 .
             2731          (b) "Dispense" is as defined in Section [ 58-17a-102 ] 58-17b-102 .
             2732          (c) "Distribute" is as defined in Section [ 58-17a-102 ] 58-17b-102 .
             2733          (d) "Drug outlet" means:
             2734          (i) [a drug outlet] a pharmacy or pharmaceutical facility as defined in Section
             2735      [ 58-17a-102 ] 58-17b-102 ; or
             2736          (ii) a person with the authority to engage in the dispensing, delivering, manufacturing,
             2737      or wholesaling of prescription drugs or devices outside of the state under the law of the
             2738      jurisdiction in which the person operates.
             2739          (e) "Health care provider" means:
             2740          (i) a person who is a health care provider, as defined in Section 78-14-3 , with the
             2741      authority under Title 58, Occupations and Professions, to prescribe, dispense, or administer
             2742      prescription drugs or devices; or
             2743          (ii) a person outside of the state with the authority to prescribe, dispense, or administer
             2744      prescription drugs or devices under the law of the jurisdiction in which the person practices.
             2745          (f) "Nonschedule drug or device" means:
             2746          (i) a prescription drug or device, as defined in Section [ 58-17a-102 ] 58-17b-102 ,
             2747      except that it does not include controlled substances, as defined in Section 58-37-2 ; or
             2748          (ii) a nonprescription drug, as defined in Section [ 58-17a-102 ] 58-17b-102 .
             2749          (g) "Prescription drug or device" is as defined in Section [ 58-17a-102 ] 58-17b-102 .
             2750          (2) A drug outlet is not subject to civil liability for an injury or death resulting from the
             2751      defective condition of a nonschedule drug or device that the drug outlet distributes at no
             2752      charge, in good faith, and for a charitable purpose to a drug outlet or health care provider for
             2753      ultimate use by a needy person, provided that:
             2754          (a) the drug outlet complies with applicable state and federal laws regarding the
             2755      storage, handling, and distribution of the nonschedule drug or device; and



Text Box

- 90 -
             2756
         (b) the injury or death is not the result of any act or omission of the drug outlet that
             2757      constitutes gross negligence, recklessness, or intentional misconduct.
             2758          (3) A health care provider is not subject to civil liability for an injury or death resulting
             2759      from the defective condition of a nonschedule drug or device that the health care provider
             2760      distributes to a drug outlet or health care provider for ultimate use by a needy person or directly
             2761      administers, dispenses, or distributes to a needy person, provided that:
             2762          (a) the health care provider complies with applicable state and federal laws regarding
             2763      the storage, handling, distribution, dispensing, and administration of the nonschedule drug or
             2764      device;
             2765          (b) the injury or death is not the result of any act or omission of the health care
             2766      provider that constitutes gross negligence, recklessness, or intentional misconduct; and
             2767          (c) in the event that the health care provider directly administers, distributes, or
             2768      dispenses the nonschedule drug or device to the needy person, the health care provider has
             2769      retained a consent form signed by the needy person that explains the provisions of this section
             2770      which extend liability protection for charitable donations of nonschedule drugs and devices.
             2771          (4) Nothing in this section may be construed as:
             2772          (a) permitting a person who is not authorized under Title 58, Occupations and
             2773      Professions, to operate as a drug outlet or practice as a health care provider within the state; or
             2774          (b) extending liability protection to any person who acts outside of the scope of
             2775      authority granted to that person under the laws of this state or the jurisdiction in which the
             2776      person operates or practices.
             2777          Section 62. Section 78-14-3 is amended to read:
             2778           78-14-3. Definitions.
             2779          As used in this chapter:
             2780          (1) "Audiologist" means a person licensed to practice audiology under Title 58,
             2781      Chapter 41, Speech-language Pathology and Audiology Licensing Act.
             2782          (2) "Certified social worker" means a person licensed to practice as a certified social
             2783      worker under Section [ 58-60-305 ] 58-60-205 .
             2784          (3) "Chiropractic physician" means a person licensed to practice chiropractic under
             2785      Title 58, Chapter 73, Chiropractic Physician Practice Act.
             2786          (4) "Clinical social worker" means a person licensed to practice as a clinical social



Text Box

- 91 -
             2787
     worker under Section [ 58-60-305 ] 58-60-205 .
             2788          (5) "Commissioner" means the commissioner of insurance as provided in Section
             2789      31A-2-102 .
             2790          (6) "Dental hygienist" means a person licensed to practice dental hygiene as defined in
             2791      Section 58-69-102 .
             2792          (7) "Dentist" means a person licensed to practice dentistry as defined in Section
             2793      58-69-102 .
             2794          (8) "Division" means the Division of Occupational and Professional Licensing created
             2795      in Section 58-1-103 .
             2796          (9) "Future damages" includes damages for future medical treatment, care or custody,
             2797      loss of future earnings, loss of bodily function, or future pain and suffering of the judgment
             2798      creditor.
             2799          (10) "Health care" means any act or treatment performed or furnished, or which should
             2800      have been performed or furnished, by any health care provider for, to, or on behalf of a patient
             2801      during the patient's medical care, treatment, or confinement.
             2802          (11) "Health care facility" means general acute hospitals, specialty hospitals, home
             2803      health agencies, hospices, nursing care facilities, assisted living facilities, birthing centers,
             2804      ambulatory surgical facilities, small health care facilities, health care facilities owned or
             2805      operated by health maintenance organizations, and end stage renal disease facilities.
             2806          (12) "Health care provider" includes any person, partnership, association, corporation,
             2807      or other facility or institution who causes to be rendered or who renders health care or
             2808      professional services as a hospital, health care facility, physician, registered nurse, licensed
             2809      practical nurse, nurse-midwife, dentist, dental hygienist, optometrist, clinical laboratory
             2810      technologist, pharmacist, physical therapist, podiatric physician, psychologist, chiropractic
             2811      physician, naturopathic physician, osteopathic physician, osteopathic physician and surgeon,
             2812      audiologist, speech-language pathologist, clinical social worker, certified social worker, social
             2813      service worker, marriage and family counselor, practitioner of obstetrics, or others rendering
             2814      similar care and services relating to or arising out of the health needs of persons or groups of
             2815      persons and officers, employees, or agents of any of the above acting in the course and scope of
             2816      their employment.
             2817          (13) "Hospital" means a public or private institution licensed under Title 26, Chapter



Text Box

- 92 -
             2818
     21, Health Care Facility Licensing and Inspection Act.
             2819          (14) "Licensed practical nurse" means a person licensed to practice as a licensed
             2820      practical nurse as provided in Section 58-31b-301 .
             2821          (15) "Malpractice action against a health care provider" means any action against a
             2822      health care provider, whether in contract, tort, breach of warranty, wrongful death, or
             2823      otherwise, based upon alleged personal injuries relating to or arising out of health care rendered
             2824      or which should have been rendered by the health care provider.